Podcasts about PCP

listen without ads at www.patreon.com/dopeypodcast buy tickets for dopey wood 2026 at https://www.showclix.com/event/dopeywood-2026 Today on Dopey! this week on Dopey — We reconnect with Jenni G. Rochester rave survivor, Purchase/White Plains running buddy via Aurora. They unpack decades: Jenni's attic stoner days, early acid/coke/ecstasy raves (Toronto runs, Sputnik parties, Rabbit in the Moon Doors cover), PCP bong hits, heavy heroin spiral (via Dave/Todd/DK circle), Brooklyn dope-sick chaos (doom sessions, Afrin-bottle tar smoking), California sober shift (mushrooms epiphany, divorce, working out), and current North Carolina life (California sober, thrifting, no heroin/ecstasy since kids). Jenny opens up about childhood trauma (abusive junkie dad, sexual abuse), brother's $300K safe heist gone wrong, jail/probation dodging, and cold-turkey quit post-pregnancy. Dave reflects on linked timelines (heroin origins, shared friends, Southern roots insight), misses Todd, plugs sponsors (Oro, Mountainside, Orchard, Recovery Unplugged), reads Spotify comments on Kevin McEnroe ep, teases Dopeywood 2026, and closes with listener's raw “Good So Bad” cover. Nostalgic, intense, hopeful — stay strong/toodles.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This is a preview for an Unresolved bonus episode, available for those that support the show on Patreon. If you'd like to listen along to this and other Patreon Exclusive bonus episodes, become a supporter at https://patreon.com/unresolvedpod or by clicking on the link below: The Titanic Poisoning - Unresolved (Patreon)Become a supporter of this podcast: https://www.spreaker.com/podcast/unresolved--3266604/support.

In this standout episode of Next Steps 4 Seniors: Conversations on Aging, we’re bringing back an audience favorite: our eye-opening interview with Nurse Practitioner Liz Jackson from Henry Ford Hospital. Liz breaks down the B.E.F.A.S.T. method for spotting stroke symptoms early, dives into the different types of strokes, and explains why timing is everything when it comes to treatment. We also tackle the red flags of heart attacks, the sneaky signs of vascular disease (yes, even leg cramping!), and how managing conditions like high blood pressure and diabetes can be game-changers. Early detection = lives saved. This episode is packed with info that could protect you or someone you love. Every week brings two ways to grow: Tuesdays dive into the physical next steps with real-life guidance for seniors and families, and Fridays uplift the heart with spiritual and emotional next steps—encouragement, faith, and hope for the journey ahead. To learn more about Next Steps 4 Seniors, contact us at 248-651-5010 or visit us online at www.nextsteps4seniors.com Find us on YouTube at https://www.youtube.com/@nextsteps4seniorsLearn more : https://omny.fm/shows/next-steps-4-seniors-with-wendy-jonesSee omnystudio.com/listener for privacy information.

PCP Guides: supporting neurodivergent kids part 1 is out! Hi beautiful PCP community! We asked you what you'd like us to cover in future episodes and so many of you asked for topics we have covered in our 4 year back catalogue. After a team huddle we are excited to announce PCP Guides!!! We will reflect on previous episodes covering requested topics with a reflection at the beginning, new resources within our free patreon community and a live Q&A to diver deeply into where the textbooks meet real life. First cab off the rank is neurodiversity and in part 1 we look back at episode 58 Blade Runner & neurodiversity. It was emotional, practical and we hope it helps to guide you in some small way.

In this episode of Communicable, Navaneeth Narayanan and Josh Nosanchuk invite Virginie Lemiale and Elie Azoulay (Paris, France) as well as fellow editor Emily McDonald (Montreal, Canada)—this time as guest—to discuss adjunctive steroid therapy for pneumocystis pneumonia (PCP) in HIV-negative individuals. In 2025, Lemiale and Azoulay published results from their double-blind, randomised controlled trial investigating steroid treatment for severe Pneumocystis jirovecii pneumonia (PIC trial) in the Lancet Respiratory Medicine [1]. At first glance, one might dismiss the study's clinical impact due the ‘negative' result of  the primary outcome, mortality at 28 days, which just missed a statistically significant difference between groups. There was a clinical difference, however, and all other outcomes, including 90-day mortality, were significantly different between groups. Understanding how pivotal these results were to clinical practice, McDonald and colleagues sought to contextualise the results of the PIC trial through a Bayesian analysis in a follow-up publication [2]. While the discussion provides useful clinical commentary, it also helps both to demystify Bayesian analysis and to call attention to what might be lost with strict or overly concrete interpretations of traditional frequentist analyses. This episode was peer reviewed by Arjana Zerja from the Mother Theresa University Hospital Center, Tirana, Albania.ReferencesLemiale V, et al. Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2025;13(9):800-808. doi:10.1016/S2213-2600(25)00125-0.Lee TC, Albuquerque AM, McDonald EG. Contextualizing the use of corticosteroids in severe Pneumocystis jirovecii pneumonia through a Bayesian lens. CMI Commun. 2025;2(4):105141. doi:10.1016/j.cmicom.2025.105141.

In this episode, Dr. Damanjeet Chaubey, Vice President of Clinical Affairs at Clover Health, shares how payer provider relationships are evolving under cost and workforce pressures and where plans often fall short in operational execution. She discusses technology enabled, PCP centric, and home based care models as critical levers for managing utilization, improving outcomes, and sustaining Medicare Advantage performance.

Hello, all you and the Relentless Health Tribe trying to figure out how to do right by patients and the folks footing the bill. Welcome to it. This is episode 499, one episode before episode 500. So, come back next week for that one. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. All right, so today, let's talk about the inches that are all around us. Let's find some. Musculoskeletal spend, otherwise known as MSK spend, for any given plan sponsor adds up to the tune of something like 20% or 30% of total plan spending, depending on the member demographic. MSK rolls in at $16 PMPM, I just saw, according to a report Keith Passwater sent me a couple of weeks ago. It's the third most costly spend apparently overall. And it's easy to see why, right? On any given day, odds are good any given plan member is gonna do something that, in hindsight, was fairly obviously a bad idea and wind up getting hurt in some low-acuity way. For example, I remember that one time I twisted my ankle on a curb getting outta my car. Given the right space, enough time, and concentration, I can do the worst parking job you've ever seen in your life and manage to twist my ankle in the process. But I digress. Here's the point. MSK spend adds up really fast. Add to that something like 50% of spine surgeries are said to be unnecessary. The same thing goes true from injuries like twisted ankles, for example, that would have healed themselves without an ER visit, without any intervention aside from ice, rest, and elevate. Because it turns out that something like 80% of those twisted-ankle, banged-up-the-back types of MSK injuries are actually low acuity, and a huge percentage of those will heal by themselves. On that point, let me bring in some context here, some late-breaking news. I was reading Dana Prommel's newsletter. She wrote, and I'm reading this, she wrote, "The 2026 National Healthcare Expenditure data reports are out, and it is another sobering reflection of our current system. Personal healthcare spending has surged by over 8%, and our healthcare spend as a share of the GDP has followed that same aggressive trajectory." Then Dana writes, "The most troubling takeaway from the 2026 report is the lack of a 'health dividend.' Despite [this] 8% increase in spending, we aren't seeing a corresponding 8% increase in longevity, wellness, or chronic disease management. People aren't getting significantly healthier; they are just getting more 'care.' And that 'care' isn't always good care, or the right care, or care by the right type of clinician, at the right time, in the right setting." Is that not the perfect segue or what? Because this is what we're talking about on the show today in regard to, again, MSK care—care that can wind up costing millions of dollars across plan members, and it might be unnecessary because, again, the twisted ankle or the pain in the lower back would have healed itself without any care, without an ER visit. But if an ER visit was had, that patient probably is gonna wind up with a bunch of imaging. Probably is gonna wind up with a referral to a surgeon. And now there's a surgery scheduled, and the patient has been off work for however long all that took. There's a lot of direct and indirect costs that may or may not add up to any given health dividend or health span or whatever you wanna call it—better quality of life.   Why does all this happen? How does it happen? One reason is what Dr. Jay Kimmel calls the white space of MSK care. This is where a patient does a truly breathtaking job parking the car, twists her ankle, starts to swell up, and now a decision has to be made: Go to the ER. Go to urgent care. Go home. Or what if it's a parent making this choice for a kid? In the olden days, maybe that patient would've called up his or her longtime family doctor and asked what to do, and maybe if that longtime family doctor didn't know, he or she would have called up the local ortho and gotten their opinion. Or maybe the two were sitting together in the doctor's lounge at the time, or maybe they rounded together in the hospital and, and, and … There used to be lots of opportunities for spontaneous questions and answers and curbside consults. But not today most of the time, really, unless you're a patient with a doctor in the family. But even for a PCP, who wants an ortho consult? Amy Scanlan, MD, and I discussed this quite a bit in an earlier episode (EP402). There's no doctor lounges anymore. There's no coffee klatch down in radiology either. There's just a lot of cultural shifts, in other words. But all of this, everything I have said thus far, all adds up to one big takeaway: These excess costs that don't have commensurate improved clinical outcomes, they happen because patients are on their own to triage themselves. They look at their black-and-blue whatever, or they're standing there listening to their kid cry and they are deciding what to do. And the thing is, if they choose the ER—because, again, they don't have a doctor, anybody they can just call with the right kind of clinical background—once they head into that ER and sit there for six hours and demand an MRI because now it has to be worth their time because they sat there for six hours; but now there's a false positive and the ER docs are being conservative because of malpractice or whatever and they refer them to some sort of surgeon … Look, everybody's doing their best with the information that they have at the time, but you can see how easy it is for a person to avoidably wind up costing a lot of money for a musculoskeletal injury that would have healed by itself. So, yeah, let's talk about how we can get patients some help in that so-called white space. How can we get them, triage before the triage, as I managed to say more than once in the conversation that follows? Let's get them on a good trajectory to start. Today, my guest is Dr. Jay Kimmel. Dr. Kimmel is an orthopedic surgeon, and he's been in practice in Connecticut for over 35 years. He and Steve Schutzer, MD, co-founded Upswing Health. I talked with Dr. Steve Schutzer about Centers of Excellence in an earlier episode (EP294). Upswing Health provides members with the opportunity to talk with an athletic trainer within 15 minutes and an orthopedic specialist within 24 hours. So, instead of having a panic attack of indecision and ultimately winding up in the ER, getting coughed on in the waiting room, members have somebody helping them in this white space so they can get triaged before the triage. I need to thank Upswing Health. I am so appreciative they donated some financial support to cover the costs of this episode. This podcast is sponsored by Aventria Health Group with an assist from Upswing Health. Also mentioned in this episode are Upswing Health; Keith Passwater; Dana Prommel; Amy Scanlan, MD; Steve Schutzer, MD; Eric Bricker, MD; Al Lewis; Nikki King, DHA; Matt McQuide; Christine Hale, MD, MBA; and Chris Deacon. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here.   You can learn more at upswinghealth.com and follow Dr. Kimmel on LinkedIn.   Jay Kimmel, MD, is the president and co-founder of Upswing Health, the country's first virtual orthopedic clinic. He founded Upswing with Steve Schutzer, MD, to rapidly assess, triage, and manage orthopedic conditions in a cost-effective, high-value manner, helping patients avoid unnecessary imaging, procedures, and delays in care. Dr. Kimmel had a long and distinguished career as a practicing orthopedic surgeon with Advanced Orthopedics New England. He earned his undergraduate degree from Cornell University and his medical degree from the University of Rochester. He completed his orthopedic residency at Columbia Presbyterian Medical Center, where he trained with leaders in shoulder surgery, followed by a sports medicine fellowship at Temple University Center for Sports Medicine, where he participated in the care of Division I collegiate athletes. He is board-certified in orthopedic surgery and is a Fellow of the American Academy of Orthopedic Surgeons. Dr. Kimmel specializes in sports medicine with an emphasis on shoulder and knee injuries and holds a subspecialty certificate in orthopedic sports medicine from the American Board of Orthopedic Surgery. He is also a member of the American Orthopedic Society for Sports Medicine. Dr. Kimmel co-founded the Connecticut Sports Medicine Institute at Saint Francis Hospital, a multidisciplinary center dedicated to providing high-quality care for athletes at all levels, and served as its co-director for many years. He has a strong commitment to education and served for over 20 years as an assistant clinical professor in both family medicine and orthopedics at the University of Connecticut. He has also served as a team physician at the professional, collegiate, and high school levels.   07:49 EP472 with Eric Bricker, MD, on high-cost claimants. 08:01 What is the "white space" in MSK spend? 10:43 Statistics on Connecticut's spending on plan members with low-acuity MSK injuries. 13:30 How back pain also easily transitions from a low-acuity issue to a high-acuity problem. 15:11 How plan sponsors can detect their white space downstream spend. 16:58 EP464 with Al Lewis. 17:02 EP470 with Nikki King, DHA. 18:15 Why where patients start their journey often dictates where they wind up and how costly that medical pathway is. 20:48 Where PCPs fit into this MSK spend issue. 25:26 EP468 with Matt McQuide. 25:34 EP471 with Christine Hale, MD, MBA. 25:39 Why access is key.   You can learn more at upswinghealth.com and follow Dr. Kimmel on LinkedIn.   Jay Kimmel, MD, of @upswinghealth discusses #MSKspend on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation #musculoskeletal   Recent past interviews: Click a guest's name for their latest RHV episode! Mark Noel, Gary Campbell (Take Two: EP341), Zack Kanter, Mark Newman, Stacey Richter (INBW45), Stacey Richter (INBW44), Marilyn Bartlett (Encore! EP450), Dr Mick Connors  

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.Topics covered include: Methods of Assessing PBC Disease ProgressionNewer Agents for Second-line Treatment of PBCPrioritizing Symptom Management and Quality of Life With PBC TreatmentPresenters:Christopher L. Bowlus, MDLena Valenta Professor and ChiefDivision of Gastroenterology and HepatologySchool of Medicine University of California Davis Sacramento, CaliforniaSonal Kumar, MD, MPHAssistant Professor of MedicineDivision of Gastroenterology and HepatologyWeill Cornell Medical CollegeNew York, New YorkLink to full program: https://bit.ly/43nHx6UGet access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jack brings the latest PCP podcast to the latest Arne Press conference, analysing the key talking points, the tone behind the answers, and what was really being said beneath the surface. From pointed questions to telling reactions, this is a sharp, no-nonsense breakdown of a presser that raised more than a few eyebrows ahead of the Magpies' next test. Learn more about your ad choices. Visit podcastchoices.com/adchoices

O livro “Percursos Clandestinos Antifascistas” conta a história de uma família que lutou contra o fascismo em Portugal, durante a ditadura do Estado Novo. As memórias foram escritas por Gonçalo Ramos Rodrigues, hoje com 93 anos, mas que tinha apenas nove quando entrou na clandestinidade com os pais e os irmãos. “Este livro fala de um período em que eu vivi na clandestinidade”, começa por contar Gonçalo Ramos Rodrigues, na sua casa, na zona de Paris, pouco tempo depois de publicar “Percursos Clandestinos Antifascistas”. A conversa sobre este livro e a sua publicação estavam prometidas há quase dois anos, quando Gonçalo recebeu a RFI para nos contar a sua história, no âmbito dos 50 anos da Revolução dos Cravos. “Percursos Clandestinos Antifascistas” conta a história de uma família que se dedicou totalmente à luta contra o fascismo em Portugal, durante a ditadura do Estado Novo. As memórias foram sendo escritas por Gonçalo, hoje com 93 anos, mas que tinha apenas nove quando entrou na clandestinidade com os pais e os irmãos. A luta começou por ser feita em casas e tipografias clandestinas, pilares da luta do partido comunista, primeiro em família e depois separados e sem notícias uns dos outros para não comprometerem ninguém. O irmão viria a ter a sua própria tipografia clandestina, uma irmã viria a ser a locutora principal da Rádio Portugal Livre, a outra a voz da Radio Moscovo. Os pais acabariam denunciados e passariam anos nas prisões de Caxias e de Peniche, enquanto Gonçalo daria o salto para Paris. “Estes episódios foram escritos para que os meus netos, quando tivessem já idade de reflectir nestas coisas, pudessem saber que o avô também participou na luta pela liberdade em Portugal porque nunca foi minha intenção e não me passou pela cabeça ser publicado”, conta. O livro foi mesmo publicado com o apoio da Câmara Municipal de Loulé, o concelho do Sul de Portugal de onde ele e a sua família são oriundos. O trabalho é também uma homenagem aos pais e à sua abnegação na luta pela liberdade. Gonçalo Ramos Rodrigues começa por contar que foi em 1951 que os pais entraram na clandestinidade com os seus quatro filhos, depois de terem vendido a casa construída com as poupanças feitas em França e de terem oferecido esse dinheiro ao Partido Comunista. Com os pais, passou 12 anos na clandestinidade, a viver em casas e tipografias clandestinas: editaram jornais do partido, como o “Avante”, o “Militante”, “A Terra”, o “Corticeiro”, e outros materiais; abrigaram camaradas e acolheram reuniões do partido proibido pela ditadura. Mais tarde, em 1963, quando já não estava com os pais, estes foram presos pela polícia política. Manuel, o pai, passou sete anos no Forte de Peniche. A mãe, Lucrécia, esteve seis anos e meio em Caxias. Foi só em 1966, já em Paris, que Gonçalo passou a conhecer o paradeiro dos pais, graças a um camarada do partido que conheceu nos bastidores da festa do jornal comunista Humanité. “Olha, os teus pais estão presos desde 1963. O teu pai está em Peniche e a tua mãe está em Caxias”, revelou-lhe o camarada. “Imagine-se o quanto este episódio me entristeceu e, ao mesmo tempo, me encorajou para lutar pelos ideais que os levaram à prisão”, recorda à RFI. O motivo de detenção de Manuel e Lucrécia era serem “membros e funcionários do PCP” e por exercerem as chamadas “actividades delituosas contra a segurança do Estado”. Ou seja, por imprimirem materiais com palavras de ordem para as lutas que os comunistas organizavam contra o regime de Salazar. Ao longo das páginas do seu livro, Gonçalo remonta aos tempos em que lutou com os pais, desde as casas que eram “pontos de apoio” para os camaradas comunistas na clandestinidade, às tipografias clandestinas. Descreve que “mentir era uma arte” num dia-a-dia em que se vivia com falsas identidades e se mudava constantemente de casa, em que de dia se trabalhava na quinta e à noite na tipografia. “Já tinha 14 anos e a minha irmã mais nova tinha nove. Os dois, mesmo crianças, éramos os principais, digamos, compositores. Chamava-se compor os textos com as letras de chumbo que depois eram inseridas no prelo para impressão (…) Era eu quem sabia melhor o português de todos os da casa porque o meu pai quase não sabia ler, a minha mãe só aprendeu a escrever na prisão de Caxias, quando esteve seis anos presa, e a minha irmã ainda menos sabia. Quem corrigia os textos, as gralhas, tudo o que havia, era o Gonçalo”, lembra, ainda, à RFI. A repressão e a detenção de camaradas obrigava a intensos “cuidados conspirativos” e Gonçalo foi depois viver sozinho em diferentes cidades. Aos 24 anos foi “a salto” para França, onde militou na Comissão de Solidariedade aos Presos Políticos e participou nas brigadas de distribuição de propaganda e de recolha de fundos para ajudar os que estavam nas cadeias da ditadura portuguesa. Em Paris, foi várias vezes interrogado por funcionários da então DST, Direcção de Segurança Territorial – equivalente aos serviços de informações – que conheciam o seu percurso de opositor político ao regime português. Por terras de França, a luta fez-se ao lado da esposa, Maria do Céu, com quem deveria ter casado em Maio de 68, mas as greves e manifestações históricas desse mês adiaram a boda que aconteceu em Junho, mas ainda com gases lacrimogéneo a apimentar a história. “Mesmo depois de chegar aqui, em Janeiro de 1966 até ao 25 de Abril de 1974, estivemos sempre na brecha, sempre na luta em tudo o que aqui se fazia contra o regime em Portugal. A minha companheira sempre me acompanhou durante todo este período, trabalhou muito mais do que devia porque eu estava sempre ocupado com reuniões infindáveis e quase diárias. Ela trabalhava também e tínhamos uma filha e ela carregava com o trabalho todo da casa e ainda quando podia, ela assistia a tudo o que era manifestações de rua e debates que se faziam aqui em França até ao 25 de Abril, até ao dia em que a gente acordou ainda sem saber se estávamos livres, mas já com uma grande esperança de estarmos livres.” Cinquenta e dois anos depois do 25 de Abril de 1974 e do fim da ditadura do Estado Novo, o livro “Percursos Clandestinos Antifascistas” recorda os tempos sombrios da perseguição política, da miséria, da prisão e da tortura de quem lutava contra o fascismo e ansiava pela liberdade. O livro é também um alerta perante a subida histórica da extrema-direita meio século depois em Portugal.

The European Motor show starts this weekend in Dublin. There'll be plenty of glossy new vehicles on show but also a lot more hands-on experiences rather than red ropes for would-be motorists. Close Brothers provided finance for 12,000 car purchases in Ireland last year whether through Hire purchases or PCP deals. Although buying a new car has soared in this decade, the demand for financing the deal has increased with it. Donal Murphy the Chief Executive of Close Brothers Motor Finance joined Joe on the show this morning.

Co-hosts Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and Holly Knotowicz, a speech-language pathologist living with EoE who serves on APFED's Health Sciences Advisory Council, interview Beth Morgan, a medical billing advocate and consultant, on navigating your medical bills. Disclaimer: The information provided in this podcast is designed to support, not replace, the relationship between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:51] Co-host Ryan Piansky introduces this episode, brought to you thanks to the support of Education Partners GSK, Sanofi, Regeneron, and Takeda. Ryan introduces co-host Holly Knotowicz.   [1:12] Holly introduces today's topic, Medical Billing, and today's guest, Beth Morgan, a medical billing advocate and consultant.   [1:31] Beth says a medical billing consultant is an individual who assists someone with medical bills to make sure that they are accurate and correct, and that they match the medical records, which are notes that the provider makes.   [1:48] The medical billing consultant or advocate can make sure the bills are paid correctly and that the charges are within the reasonable prices for the treatment area.   [2:19] Beth explains how medical insurance covers healthcare costs. It protects the patients and providers from very high expenses. It can also possibly help with the stress of navigating healthcare systems.   [2:36] The goals of medical insurance are to help cover patient costs for treatments, preventive care, and prescriptions. It can also provide resources for telehealth visits or support visits, if needed.   [2:48] With a telehealth visit, you, the patient, have to make sure that your insurance plan covers and allows it. Sometimes, the cost of a telehealth visit can be more than if you were to go to the office.   [3:27] Beth says most people look at what insurance will cost them per month. They fail to look at their yearly deductible, per person or per family, their prescription costs, or what it will cost to see a specialist. They don't consider what therapies will cost them.   [4:08] Beth had a client whose insurance company would only cover in-state providers. If she went out of state, she wouldn't be covered; even an emergency might not be covered. You have to look at the "nitty-gritty" of the policy.   [4:32] Beth says the biggest things are the deductible and copay, or co-insurance. Don't just look at the cost. Most people will take out the $10,000 or $5,000 deductible plans, saying it only costs $75 for the entire family. What does it actually cover?   [5:00] You don't want sudden surprises when you get to the emergency room. You want to know what your copay will be when you go into an emergency room.   [5:11] Holly agrees with Beth and notes that Real Talk listeners have chronic illness. Some have multiple illnesses. When you're selecting insurance plans, those are the things you have to look into.   [5:27] Patients with EoE often need endoscopies and other specialized procedures. Holly asks for tips on how someone can know what an endoscopy or other procedure will potentially cost.   [5:41] Beth says to ask the doctor what the CPT code is. That's the code that describes the treatment. Then look up that CPT code on the insurance company website. They will show an estimated cost for that treatment, for a rough idea of the cost.   [6:10] Keep in mind that it will not tell you what the providers will charge or what the hospital fee will be.   [6:21] Holly says she has EoE and MS. She asks a social worker for the CPT code for every procedure so she has a record to double-check when the bill comes. The CPT code is the key.   [6:50] Holly is a speech pathologist who does feeding therapy. She says to look at your plan to see if therapy is a copay or if it goes toward your deductible. If it goes toward your deductible, it will be very expensive until you meet that deductible.   [7:10] People living with an eosinophilic disorder may find themselves in the ER for a variety of reasons. Holly was there this week with a food impaction. For others, it could be a pain flare or an asthma attack.   [7:26] Holly asks how families can be prepared for medical bills related to emergency care.   [7:40] Beth replies, You also have on that bill the ER doctor and the ambulance fee, including mileage, which must be accurate or rounded up to the next mile. Track the mileage in your car.   [8:43] Who will be transporting you: volunteers from the fire department, a hospital ambulance, or an outside ambulance? Are you going under Basic Life Support or Advanced Life Support?   [9:05] Once you get to the ER, have someone else with you who can advocate for you. Sometimes, staff will bring you forms to sign before they treat you. If you're in a lot of pain, you're not in your right mind to sign those forms; you're only thinking of your pain.   [9:53] Ryan says a friend of his went to his doctor's office for a prescription refill. Typically, he pays a $25.00 copay per visit. This prescription refill visit was not covered in the same way as other visits, and he received a bill for over $200. The insurance company only covers maintenance appointments.   [10:48] Beth says an Explanation of Benefits (EOB) comes from your insurance company. It shows what the doctor charged, what the insurance company paid, and what you owe.   [11:07] A medical bill is what your provider sends you. Beth always asks the provider to send the bill after the insurance company has paid. That way, you know the insurance company has paid on the bill, and there are no surprises.   [11:25] When the provider bills you, the insurance company may have paid something on it, or it may have applied the bill toward your deductible or copay.   [11:44] When a patient receives a provider bill, Beth says they can go to a company called FAIR Health to see today's rates of what should be charged. Insurance companies negotiate rates with providers.   [12:04] Beth says that an out-of-network provider of physical therapy can charge, for example, $160 a visit, and you have to pay out-of-pocket. They can send it to your insurance company, and the insurance company may only pay 30% of the charge.   [12:20] Call the insurance company to ask questions about your insurance. Utilize the estimated costs feature on your insurance company's website.   [12:32] Beth says she always keeps the page of her health insurance booklet that shows what a PCP office visit, or outpatient specialist visit, will cost. Most people get the book and toss it out, but that page is very helpful.   [12:53] If you go into the emergency room, you might have a $300 copay just to be seen, but if you ask them to bill you after they bill your insurance company, most places should respect that.   [13:11] Beth says that most of the time, the red flags that she looks for on medical bills are supply items. Most supply items are included in the cost of the hospital visit. She says a surgical hospital visit is like an oil change.   [13:42] Beth compares a surgery to an oil and filter change. When you go in for surgery, the drape they put over you is included. You only pay for the supply items you walk out with.   [15:15] Beth says, If there's something wrong on your medical bill, your insurance rep may not know the answer. Most insurance companies have outsourced their billing questions. Start with the billing department of the hospital.   [15:35] Ask, "Why did you bill me for an X, Y, Z, when I didn't have an X, Y, Z? I had an A, B, C. Can we re-examine this, please?" Another thing is to go back to your provider.    [15:52] The provider can request medical notes, which are part of your patient record, and you can look at them yourself. Beth says, for hospital stays, she always tells people to ask for a completely itemized bill.   [16:12] Holly agrees.   [16:20] Beth says you have to look at the itemized bill. Does something make sense to you? Does it look a little unreasonable? That's easy to see.   [16:26] Ryan says when you call your insurance company, it can be time-consuming to reach the person who can answer your question, but it's important to do so, especially for expensive things like hospital stays. Doctor's office visits can also be expensive.   [16:58] Something else that can be tricky is medications. Especially for those of us with chronic illnesses and the rare diseases that we work with here at APFED, costs can be quite high for some of the medications patients take.   [17:20] Beth says, When you call the insurance company, ask for the name of the person you are talking to. Write down the name, date, and time that you spoke to the person. Ask them for a call reference number, where they are located, and what was discussed so you have record of that information.   [18:04] For medications, you can look up prices through GoodRx or other prescription websites that might give you an estimate of what the possible cost could be.   [18:20] If your provider states on the prescription, Do not substitute or give generics, you might be paying full price. Otherwise, most pharmacies will offer you the generics.   [18:35] Holly asks, If someone feels overwhelmed by billing or insurance issues, where can they go for help? Are there resources that you recommend?   [18:45] Beth says, There is a patient advocate group, with individuals across all 50 states, that will help you with medical bills and advise you on everything else. Your provider's office or the facility also might have someone who could help you.   [19:11] Beth says she would look for patient advocates like social workers. Make sure whoever you work with has medical knowledge.    [19:26] Ryan says, talking with the billing department can feel a little antagonistic, but they are there to help you. If you talk to the right people and ask the right questions, you can figure out what's going on and get some answers.   [19:40] Beth agrees and says, Always write down your questions. Ryan adds, Always write down the answers and ask the name of the person you are talking to. Beth reminds you to ask for the call reference number. They keep a record of every call.   [20:09] Beth's last words about medical billing: "The most important thing is keeping track of what's going on. I recommend using a calendar, like a planner, that you can write 'I saw Dr. J. Smith, EoE Specialist. Discussed flare-ups,' and the time and date."   [20:30] "Keep a record. That way, in this planner, you can go back to it and match it up. If possible, have someone with you or on the phone with you when you talk with them. The other person can take notes, which is very important."   [20:39] "You need to have the backup and the understanding. If you don't understand something, ask questions." Ryan says, Those are good tips for everyone.   [21:14] For our listeners who would like to learn more about eosinophilic disorders, please visit apfed.org.   [21:20] To learn more about navigating healthcare in the United States with eosinophilic disorders, please check out NavigateEOSCare.org. We'll include links to both of those in the show notes below.   [21:29] Ryan thanks Beth Morgan for joining us today. This was an insightful conversation for everyone. Beth thanks Ryan and Holly for having her on.   [21:35] Holly also thanks APFED's Education Partners GSK, Sanofi, Regeneron, and Takeda for supporting this episode.   Mentioned in This Episode: Beth Morgan, President & CEO of Medical Bill Detectives NavigateEOSCare.org Patient Advocate Foundation   APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast Apfed.org apfed.org/specialist apfed.org/connections apfed.org/research/clinical-trials   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of GSK, Sanofi, Regeneron, and Takeda.   Tweetables:   "Medical insurance covers healthcare costs. It protects the patients and caregivers from very high expenses. It can also possibly help with the stress of navigating the healthcare systems." — Beth Morgan   "Most people look at what insurance will cost them per month. They fail to look at what their yearly deductible might be, per person or per family." — Beth Morgan   "Ask the doctor what the CPT code is. That's the code that describes the treatment. Then go to the insurance company's website. Most insurance plans have it. They will give you an estimated cost for that." — Beth Morgan   "Keep a record. That way, in this planner, you can go back to it and match it up. If possible, have someone with you or on the phone with you when you talk with them. The other person can take notes, which is very important." — Beth Morgan   "For hospital stays, I always tell people to ask for a completely itemized bill." — Beth Morgan   "I would look for patient advocates like social workers. Make sure whoever you work with has medical knowledge." — Beth Morgan    Guest Bio: Beth Morgan, President & CEO of Medical Bill Detectives, has been a Certified Professional Coder (CPC) and Compliance Specialist (MCS-P) since 2004. Over the past 20 years, she has worked in several areas of the medical profession, doing billing and coding for all sorts of providers. Her knowledge and expertise have enabled her to not only reduce providers' accounts receivable but also medical bills by 51%. She has access to a broad base of insurance company policy information and is an information contributor to radio and TV shows, as well as magazine articles. Medical Bill Detectives reviews medical bills for errors and overcharges, reducing them to Usual Reasonable and Customary charges, for negotiating discounts on medical bills. We are able to review bills for all 50 states.   Aphadvocates.org/speakers/beth-morgan/ Seakexperts.com/members/7326-beth-morgan 

O Estado (ou talvez não), a CGTP (que repete os argumentos do PCP) e António José Seguro (que pelos vistos não quer debates) são o Bom, o Mau e o Vilão.See omnystudio.com/listener for privacy information.

Epi 8In this powerful episode of The Cutting Edge Podcast, Mel and Ashlyn Douglass-Barnes (LCSW & bariatric + skin removal patient) sit down with board-certified plastic surgeon Dr. Omar E. Beidas to talk about the things no one prepares you for after massive weight loss and plastic surgery.

BE, PCP e Livre criticam "subserviência" do Executivo. Já IL e JPP aceitam posição do MNE e lembram regime opressor de Maduro.See omnystudio.com/listener for privacy information.

⏰ If You Had One Day, One Week, One Month Left to Live... Amanda, Laura, and Kendra tackle the most clarifying question as we start 2026: What would you do differently if you had limited time left? This isn't about panic—it's about calibration. Without intentionality, medicine will weave into every aspect of your life. This thought experiment reveals what actually matters.

On this week's Wrap Party, Zeth is talking about the PCP-laced seafood chowder that the cast and crew of ‘Titanic' unknowingly consumed, and with your help, we make a list of the best films about poison. Plus, your emails, calls, and DMs! Become an All Access member today by visiting disgracelandpod.com. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Bernardino Soares afirma que António Filipe é o único capaz de gerar consensos à esquerda. Ana Gomes garante que o PS está unido e que candidato apoiado pelo PCP não conseguirá ir à segunda volta.See omnystudio.com/listener for privacy information.

In our final episode of the year we answer some important short questions about how we can have impact in the face of difficult challenges in the world right now. We then read out the reflections from some of the beautiful PCP community who generously share their journey. As always there is laughter and tears. Thank you all for being a part of PCP in 2025. We feel privileged to share this community with you and hope you are able to slow down and rest over the coming weeks. See you in 2026 to face the challenges and celebrate the wislows together. Love Nick and Billy.

The mystery of who drugged the cast and crew of the blockbuster Titanic is Hollywood lore. In 1996 James Cameron shot part of Titanic in Dartmouth, Nova Scotia, when someone dumped PCP into the clam chowder the team was sharing on the last night of shooting. Over 50 people ended up in hospital. There was a police investigation but the case was never solved. Over the decades theories as to who and why have sprouted. These range from disgruntled caterers to vengeful bikers to insurance scams.Canadaland decided to take up the case and look for the answer: who spiked the Titanic chowder?Host: Jesse BrownCredits: Julian Abraham (Reporter), Bruce Thorson (Senior Producer), Caleb Thompson (Mixing & Mastering) max collins (Director of Audio), Jesse Brown (Editor and Publisher)Additional Writing and Production from Rick Courtney.Fact checking by max collinsAdditional music by Audio NetworkMore information:Further Reading:“Grips are doing wheelies in wheelchairs” - VarietyJames Cameron Recalls the Night the Titanic Crew Were Spiked with PCP - CBCJames Cameron on CBC's The Q - VideoSponsors: MUBI: To stream great cinema at home, you can try MUBI free for 30 days at mubi.com/canadaland.BetterHelp: Visit https://BetterHelp.com/canadaland today to get 10% off your first month.Douglas: Douglas is giving our listeners a FREE Sleep Bundle with each mattress purchase. Get the sheets, pillows, mattress and pillow protectors FREE with your Douglas purchase today. Visit douglas.ca/canadaland to claim this offerCan't get enough Canadaland? Follow @Canadaland_Podcasts on Instagram for clips, announcements, explainers and more.If you value this podcast, support us! You'll get premium access to all our shows ad free, including early releases and bonus content. You'll also get our exclusive newsletter, discounts on merch at our store, tickets to our live and virtual events, and more than anything, you'll be a part of the solution to Canada's journalism crisis, you'll be keeping our work free and accessible to everybody. Hosted on Acast. See acast.com/privacy for more information.

In this powerful patient interview, Ray and Lisa open up about more than 25 years of weight management struggles, even while “eating like a mouse” and strictly following traditional dieting guidelines. They describe the emotional toll of feeling like their bodies were working against them—until they finally learned about food noise, the brain-driven hunger signals that make portion control and willpower-based dieting nearly impossible.Guided by their PCP and cardiologist, they began a GLP-1 medication and immediately discovered that their challenges weren't due to lack of discipline but physiology. They explain how GLP-1 therapy helped quiet food noise, curb impulse eating, and make portion control feel natural for the first time in decades.But their transformation didn't come from medication alone. Ray and Lisa share how combining GLP-1s with consistent strength training, intentional daily movement, balanced nutrition, and sustainable habits led to life-changing results — from better cholesterol and blood pressure to increased stability, stamina, and the ability to fully engage with their grandchildren again.Their story is a relatable, inspiring roadmap for anyone navigating weight loss after 40, metabolic changes, thyroid issues, menopause, emotional eating, or long-term dieting frustration. This episode highlights the science behind food noise, the importance of muscle maintenance on GLP-1s, and why a whole-body, personalized approach creates lasting change.Download the free Pound of Cure Weight Loss app from your app store today!

no inserted ads: www.patreon.com/dopeypodcastThis Week on a super classic episode of Dopey! Dave is visited by local Long Islander - Will P. AKA Hairy Tongue Will. Dave opens the show drinking Ryze mushroom coffee while talking about how cold his recording room is. He announces that Dopey will be releasing five episodes per week throughout December, including replays, Patreon teasers, deep cuts, and new interviews.He gives sobriety shoutouts — notably Lauren's three-year milestone and Maddie Veitch from Leftover Salmon celebrating her own recovery marker. He encourages listeners to email in clean-time milestones for future episodes.Dave then goes through a lengthy run of Spotify comments left on the Darrell Hammond episode. The comments range from people complaining about the “This or That” game, others defending it, jokes about possums, encouragement about psychedelics, questions about whether Darrell is truly sober, praise for the episode, frustration with the interview pacing, random remarks about Lime Drive and “Mike's Amazing Stuff,” plus multiple requests for stickers. Dave reads each comment and jokes along, sometimes offering to send merch.Ads for Mountainside and Link Diagnostics follow. Dave talks about how Mountainside is central to the history of Dopey and how Link Diagnostics offers drug testing services that help people “stay positive and test negative.”Dave then plays an LSD voicemail from Henry in San Francisco, who took two hits of acid alone in college. Henry becomes one with his bicycle, panics at a house fumigation tent he interprets as a circus, fears he'll be mutated by pesticides, runs home, listens to the Butthole Surfers, sees Aztec gods appearing from shifting ceiling patterns, and eventually rides it out. He is now 15 months sober and credits Dopey Nation for support.Next he reads an email from Jerry, who describes crazy addiction history including fighting cops on PCP, overdoses, ventilators, and robbing heroin dealers. Jerry discovered Dopey by typing “heroin” into the podcast search bar while newly out of rehab in 2018. His biggest complaint is that Dave has never watched Joe Dirt.The episode opens with your intro, then the bulk of the show is Hairy Tongue Will's massive, chaotic, detailed telling of his addiction, near-death runs, arrests, relapse cycles, dead friends, and eventual recovery.Will describes the early Long Island chaos with Richie, Mike, and Lenny—everyone strung out on heroin, crack, coke, and whatever they could get. He recalls the first serious turn: showing up to a house where Lenny was passed out after a three-day crack run, realizing “the demons are taking over.” Mike and Richie spiral deeper, and Will keeps managing to “hold it together” thanks to jobs, work ethic, and a strange electrical-job stabilizer that kept him semi-functional.He details years of DUIs, probation, manipulating drug tests, smoking crack constantly while still working 16-hour electrician shifts, and thriving socially because coworkers lived vicariously through him. He normalized chaos, missing only “one no-call/no-show every two weeks,” which he considered acceptable.Will then dives into his first short attempt at stability, living in a basement apartment. His probation officer surprises him the day after a holiday: the apartment is filled with beer cans, bongs, baggies. He fails the test, is sent back to rehab/jail cycles, and explains why Long Island addicts often choose jail over treatment. He describes his surreal time in jail—being sent to the Montauk Lighthouse on work crews, eating egg sandwiches and black-and-milds with the guards, becoming “the useful guy,” actually feeling respected and purposeful.Back outside, he tries again, fails again, collects DUIs, cycles through companies, loses jobs, hustles side work, and repeatedly relapses. A wedding night leads to another DUI. COVID hits while he's in jail. He gets out, starts working nonstop, earns money, piles cash in a closet, stacks crypto, reads self-help books, sleeps on a mattress on the floor, becomes obsessed with success and control.Then he meets a girl in Tennessee. He drinks again “successfully” only when he flies there. He builds a double life—working himself numb, drinking out of state, convincing himself he's different.Eventually, on a work trip, he gambles, wins big, drinks an old fashioned, and secretly cooks his boss's cocaine into crack. This reignites the obsession. Will starts traveling the Northeast and Midwest, repeatedly pulling crack-seeking missions: gas stations, high-crime neighborhoods, asking strangers, “I'm looking for some hard.” He builds drug contacts in Bridgeport, Dayton, Maine, Virginia, wherever the job sends him. He smokes in hotels, hallucinates blood on floors, changes rooms repeatedly.He recounts the deaths of friends:Mike, whose father turned their home into a sheet-walled trap house with dealers and bikers living inside.How Mike died with his father selling sneakers off his dead son's body.Richie, who got sober then died of fentanyl after nearly two years clean.Will's life collapses further—obsession, resentment toward God, jealousy, terminal uniqueness. He becomes a “demon,” wanting to die like his friends. He terrifies his girlfriend with delusional FaceTimes, nine-day runs, psychosis. She moves in without knowing the truth and becomes trapped in codependency.He stays high for 26 straight days, manipulates her with antihistamine allergy episodes to cover his psychosis, hides crack pipes around the house with ring cameras everywhere. He finally admits some truth, gives her $5,000 to escape, but she stays another nine months.He tells insane stories:Pretending he's a trust-fund baby to get free crackGetting shot at by a dealer after a misunderstanding over “two grams” vs “two ounces”Driving through wooded roads barefoot at gas stationsDealers trying to jump himBecoming a mule for a recently-released dealer (Ace)Near misses, violence, and pure street insanityEventually, during a pickup, he gets chased, prays for police lights, and his car breaks down. Cops descend. He gets a mountain of charges (“five decades worth”). He thinks he'll die in prison. Bail reform gets him released. He immediately uses again for 17 more days.A sober lawyer tries pushing him toward St. Christopher's. Will resists, manipulates LICR, relapses again, cancels his own insurance, tries to die, and after weeks of chaos his mother gets him re-approved. He enters St. Chris, still delusional, still dangerous.There he breaks. He admits suicidal thoughts, gets a guard stationed outside his door, hears the blunt truth—you're the worst-off guy here and you did this to yourself. It lands. Will begins working the program: spiritual direction, grief groups, codependency, meetings, kitchen duty, everything. He reconnects with his mother in sobriety. He attends court in suits provided by the facility and ultimately receives an unexpectedly generous plea deal.He comes home early, tries to run his own program, stays sober for months, but on Mother's Day runs into an old acquaintance who shows him a Newport box with a pipe inside. He relapses immediately for three days, misses Mother's Day entirely.That night, suicidal again, he receives a series of calls: first from Jordan, then from his tough sponsor, who gives him clear direction—go to a sober house, go to daily groups, go to nightly meetings, call people, build structure. Will frauds his urine to get in, but once inside, follows every instruction. He stabilizes.He recounts being 18 months sober now, having been at meetings nearly every night, with a recent slip in commitment due to chasing an “intimate partner godshot” that didn't work out. You reassure him that it's fine and that balance is part of recovery.More or less thats the whole thing! On a brand new fucko, crackead episode of that good old dopey show! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

O sindicalista Arménio Carlos considera que António Filipe tem margem para ir além do eleitorado PCP. Ainda, Marisa Matias rejeita divisões que prejudiquem a esquerda e realça um "debate cordial".See omnystudio.com/listener for privacy information.

These are a couple stories that really showcase the dangers of using PCP....

Paulo Muacho, apoiante de Jorge Pinto, aponta o dedo ao BE e PCP por não terem tido abertura para construir uma alternativa a Seguro. Vasco Cardoso afasta cenário de desistência de António Filipe.See omnystudio.com/listener for privacy information.

In our final topic of 2025 we explore what impacts the kids we care about in terms of their development and mental health. We explore the science and Dr Nick treats us to his big lessons from PCP this year. Please send in your best reflections, questions and advice for our reflection episode to share with the wonderful PCP community.

In this episode of The Fighter and the Kid, Brendan and Bryan sit down with comedian and wrestler Nick Simmons, who joins right as the guys finally address the years of Reddit hate, online criticism, and the wild narratives fans have created about the show.They dive into the hilarious but eye-opening ways women underestimate real strength, why self-defense fantasies don't match physics, and how pepper spray, bear spray, and knives work in real-world scenarios.Nick shares his insane PCP pandemic home-intruder story — including the break-ins, the stairwell fight, the loose slice of pizza, and the moment the cops let the guy go… right before he bit one officer's nose and an EMT's Achilles tendon.They compare this to the Anthony Smith intruder fight, breaking down why meth and PCP shut off the “governor” in the brain and create freak-level strength.From there, the guys get into Mongolian and Polynesian genetics, strength competitions, football concussions, stingers, and the brutal gap between normal athletes and genetic freaks.Nick also opens up about moving from NYC to Austin, meeting his girlfriend's intimidating dad, being a regular at iconic NYC clubs, and the new comedic grind of trying to get passed at The Comedy Mothership.The guys finish by roasting each other's outfits, shoes, and the chaos of performing comedy while your friends try to mess with your head backstage.A funny, honest, chaotic episode with one of the best young comics in Austin.DraftKings - Download the DraftKings Pick6 app now and use code FIGHTER. That's code FIGHTER — New DraftKings customers can play just $5, and get $50 in Pick6 credits.O'Reilly Auto Parts- https://oreillyauto.com/FIGHTERTrue Classic - True Classic - Upgrade your wardrobe and save on @trueclassic at https://trueclassic.com/fighter ! #trueclassicpodMagic Mind - https://magicmind.com/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textAt 2:17 on Thanksgiving Day 2025, Homily of Horrors entered it's 3rd season. Grab a gallon of PCP and join us as we take a dive into Zach Cregger's Sophomore film: Weapons.Music and sound effects are provided by zapslat.com and bensound.com, and the theme song is "Graveyard Shift" by Kevin MacLeod. https://creativecommons.org/licenses/by/4.0/ 

Joining me today is Derrick Broze, here to discuss his recent series, The Technocratic Trump Administration, as well as his latest update on the Fluoride Lawsuit—regarding the Trump administration's efforts to continue appealing the historic ruling that would help Make America Healthy Again. We unpack the confounding and hypocritical actions of Trump's cabinet around both topics, and how the partisan base supporting any politician in the two-party illusion is used to gaslight and "flood the zone." We also dive into the current status of the Epstein debacle, and the ever-growing control grid being built around us. !function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src="https://rumble.com/embedJS/u2q643"+(arguments[1].video?'.'+arguments[1].video:'')+"/?url="+encodeURIComponent(location.href)+"&args="+encodeURIComponent(JSON.stringify([].slice.apply(arguments))),e.parentNode.insertBefore(l,e)}})}(window, document, "script", "Rumble");   Rumble("play", {"video":"v703jre","div":"rumble_v703jre"}); Source Links: The Last American Vagabond Derrick Broze, Author at The Last American Vagabond The Pyramid of Power Crowdsource Effort! - The Conscious Resistance Network The Pyramid Of Power - The Pyramid of Power Crowdsource Effort! - The Conscious Resistance Network New Tab (22) Catherine Herridge on X: "Straight to the Point Exclusive: FBI Director Kash Patel @FBIDirectorKash said FBI is working with DOJ to meet the Epstein Files Transparency Act 30 day deadline to produce records. Herridge: "So, more charges are possible in the Epstein case? Director Patel: Based on the https://t.co/gnMVAQJXmR" / X New Tab Fluoride Lawsuit Plaintiffs Push Back Against Trump EPA In Ongoing Litigation x.com/michaelpconnett/status/1990527499789644105 Fluoride Trial Archives - The Last American Vagabond Trump's EPA Continues Biden Admin Appeal of Historic Fluoride Ruling Is Trump's EPA Planning to Continue the Appeal of the Historic Fluoride Ruling? New Tab The Technocratic Trump Administration The Technocratic Trump Administration: The Public-Private Partnership The Technocratic Trump Administration: Pressuring and Consolidating the Media FCC chair Brendan Carr leads Trump's charge against the media : NPR The Technocratic Trump Administration: The Zionist Infiltration Expands Launching the Genesis Mission – The White House (21) No Election Integrity No Republic on X: "Can you imagine the Influencers' outcry if Alejandro Mayorkas had announced this?" / X (21) Disclose.tv on X: "NOW - DOE Secretary Chris Wright says Trump's Genesis Mission is "an all-in national effort to take the power of AI and pair it with the 40,000 outstanding scientists and engineers at our national labs." https://t.co/4pnCzdKrKg" / X (21) Jason Bassler on X: "Flock Safety's CEO Garrett Langley just called the transparency activists at https://t.co/7vYVNCDLR6 “terrorists.” So, if mapping cameras is "terrorism"… what do we call mass surveillance of millions of innocent drivers? https://t.co/eEVbk7Sn5X" / X The Impending Future Of AI-Government - But Who Controls The AI? Unquenchable Thirst – Texas Data Centers Consume 50 Billion Gallons Of Water As State Grapples With Historic Drought Trump's Warp Speed, CDC's Jim O'Neill, Transhumanism & Gaza "Freedom Cities" (Technocratic Dystopia) GAZA-Great-Trust-Plan.pdf New Tab US Border Patrol Is Spying on Millions of American Drivers | WIRED Border Patrol monitors US drivers and detains Americans for ‘suspicious' travel | AP News New Tab Trump Says Calls For Military To Resist Unlawful Orders "Seditious" & DC Deployment Ruled Illegal (21) The Last American Vagabond on X: "This, as his administration begins to investigate the politicians who posted the video reinforcing that it's legal to refuse unlawful orders. This government is the laughing stock of the world. Not sure if that's deliberate or not, but I strongly consider it. #TwoPartyIllusion" / X DHS Lies About Detaining/Deporting US Citizens & Trump Reportedly Readying To Attack Venezuela (8) Aaron Reichlin-Melnick on X: "This story is WILD. Witnesses saw a man get detained by DHS six weeks ago. A friend detained with him saw him have a medical incident while detained and get taken out by an ambulance. Then he disappeared. DHS says they have no record of him. No hospital either. He's just… gone. https://t.co/5YD5maV8HU" / X (8) Aaron Reichlin-Melnick on X: "ICE went to a court in Rhode Island to arrest someone, misidentified their target and ended up surveilling a random Latino intern, and then threated to break a judge's car windows and were only stopped when court security intervened and asked them to calm down and look at IDs. https://t.co/6BAAZvpjnK" / X (9) LongTime

Curious whether red light therapy is actually legit—or just another wellness trend? In Episode 30, Allison interviews pelvic health physiotherapist Liz Frey, Director of Women's Health at Fringe, to explore the real science behind red and near-infrared light and how it may support pelvic floor function, postpartum recovery, perimenopause/menopause symptoms, pain, inflammation, and overall tissue health.We discuss how light therapy influences nitric oxide production, ATP and mitochondrial energy, circulation, collagen and elastin, and why vibration can help improve pelvic floor activation. Liz also explains blue light therapy for recurrent BV and yeast infections, plus practical tips for choosing between a wand, wrap, or panel.Limited-Time Sale (Nov 24–30): Save 25% off all Fringe red light products with code AllisonC25. Affiliate link: https://fringeheals.com/?ref=ALLISONECRAIG After Nov 30: save 10% anytime with AllisonC10.Affiliate Disclosure: We may earn a small commission if you purchase through these links at no extra cost to you.

Burnie and Ashley discuss Executive death threats, Starliner, Bitcoin crash, day trading, Scion fund closure, Wicked premiere, Titanic's PCP problem, and deli meats.

The Kensington Philadelphia Drug Market, Real Story. If there is any place that captures the raw, unfiltered reality of America's drug crisis, it is The Kensington Philadelphia Drug Market. For decades, this neighborhood has been the epicenter of open-air dealing, addiction, and human suffering, an area where people lie on sidewalks, stumble through streets, and inject or smoke drugs in plain view. Sidewalks, parks, and alleys are littered with used needles. Crowds of people slump over, “nodded out,” as if frozen in time. Law Enforcement Talk Radio Show and Podcast social media like their Facebook , Instagram , LinkedIn , Medium and other social media platforms. “It's something you have to see to believe,” one writer observed. “Whatever you've seen on Twitter (X), Facebook, Instagram, or the evening news doesn't even come close.” The intense episode now streaming on the Law Enforcement Talk Radio Show and Podcast website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform. A Marketplace of Desperation Kensington offers something few other places in America do, product variety. Fentanyl, now responsible for most overdose deaths, saturates the scene. Meth and crack mix in for users looking to combine “uppers and downers.” Even retro drugs like PCP have made a return. One user told investigators his typical order was “three down, one hard”, fentanyl for the down, crack for the hard. The Kensington Philadelphia Drug Market, Real Story.  Look for supporting articles about this and much more from Law Enforcement Talk Radio Show and Podcast in platforms like Medium , Blogspot and Linkedin . This is the reality former Philadelphia warrant investigator Tristin Kilgallon witnessed firsthand. From the Streets to the Classroom Kilgallon, who grew up near Kensington, spent years navigating these streets as part of the First Judicial District's Warrant Unit. Once a frontline investigator tasked with tracking fugitives, he later left the unit to attend law school. He became a lawyer, then a criminal justice professor, teaching the next generation of justice professionals. “I loved the job, but the danger, the low pay, and the burnout, it wears you down,” Kilgallon explains. “Kensington changes you. You see things you can't unsee.” The Kensington Philadelphia Drug Market, Real Story. Available for free on their website and streaming on Apple Podcasts, Spotify, Youtube and other podcast platforms. He now speaks openly about the realities he observed, not just in policing but also in higher education. “There's a lot of myth versus reality in the classroom,” he says. “And too often, the focus is on political indoctrination, not actual education.” The Book: A Real Story of Crime, Chaos, and Brotherhood Kilgallon co-authored the book Philly Warrant Unit with lifelong friend and fellow investigator Mark Fusetti. The two grew up on the same block, reunited professionally years later, and began working side by side in one of America's toughest fugitive-tracking units. “This book isn't a traditional cover-to-cover read,” Kilgallon says. “It's a collection of true stories, intense, funny, tragic, and real.” The authors share behind-the-scenes experiences: tense arrests, tragic overdoses, unpredictable street encounters, and the kind of dark humor only law enforcement veterans understand. Their stories paint an unfiltered portrait of policing Philadelphia during a period when Kensington's drug market became a billion-dollar enterprise and a global symbol of urban decay. The Kensington Philadelphia Drug Market, Real Story. The Law Enforcement Talk Radio Show and Podcast episode is available for free on their website , Apple Podcasts , Spotify and most major podcast platforms. His interview can be found on The Law Enforcement Talk Radio Show and Podcast website, on Apple podcasts, Spotify, Youtube and on LinkedIn, Facebook, Instagram, and across most podcast platforms where listeners crave authentic law enforcement stories. Kensington: A Neighborhood Consumed Kensington was once a thriving industrial hub. When factories shut down during the 1960s and deindustrialization hollowed out the area, poverty, abandonment, and neglect took root. Vacant factories became havens for dealing and drug use. The Market-Frankford Line offered easy access. By the late 1990s, Kensington had become the place to buy heroin on the East Coast. As Kilgallon puts it: “The drug market didn't just appear, it grew like a parasite. And it's been feeding off the neighborhood for generations.” The full podcast episode is streaming now on Apple Podcasts, Spotify, and across Facebook, Instagram, and LinkedIn. Today, fentanyl, xylazine, meth, and crack dominate. Doctors and treatment centers struggle to help people addicted to substances that often leave them disfigured or near death. Residents face homelessness, encampments, violence, and crushing economic inequality. “Kensington has become the Las Vegas of Drugs,” Kilgallon says. “It's shocking, but it's the truth.” The Kensington Philadelphia Drug Market, Real Story. A Real Story Worth Hearing Kilgallon's firsthand insights, on policing, addiction, community collapse, and the failures of both policy and academia, make him a powerful voice in conversations about Kensington's future. His Real Story matters because it cuts through the political noise and media sensationalism. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. Whether you've seen snippets on X, listened to interviews on Apple Podcasts, streamed discussions on Spotify, or followed the dialogue on LinkedIn, one thing is clear: Kensington's crisis is not just a headline. It is a human story. A community story. A story with no easy answers. And as Kilgallon's book, career, and commentary show, the only way forward is through honesty, accountability, and a willingness to face the streets as they truly are. The Kensington Philadelphia Drug Market, Real Story. Available for free on their website and streaming on Apple Podcasts, Spotify, and other podcast platforms. Background song Hurricane is used with permission from the band Dark Horse Flyer. You can contact John J. “Jay” Wiley by email at Jay@letradio.com , or learn more about him on their website . Get the latest news articles, without all the bias and spin, from the Law Enforcement Talk Radio Show and Podcast on Medium , which is free. “If you enjoy the show,” John Jay Wiley adds, “please share it with a friend or two, or three. And if you're able to leave an honest rating or review, it would be deeply appreciated.” The Law Enforcement Talk Radio Show and Podcast is available for free on Apple Podcasts, Spotify, YouTube, and LETRadio.com, among many other platforms. Stay connected with updates and future episodes by following the show on Facebook, Instagram, LinkedIn, their website and other Social Media Platforms. Find a wide variety of great podcasts online at The Podcast Zone Facebook Page , look for the one with the bright green logo. Be sure to check out our website . Be sure to follow us on X , Instagram , Facebook, Pinterest, Linkedin and other social media platforms for the latest episodes and news. Listeners can tune in on the Law Enforcement Talk Radio Show website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform and follow updates on Facebook, Instagram, and other major News outlets. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. You can help contribute money to make the Gunrunner Movie . The film that Hollywood won't touch. It is about a now Retired Police Officer that was shot 6 times while investigating Gunrunning. He died 3 times during Medical treatment and was resuscitated. You can join the fight by giving a monetary “gift” to help ensure the making of his film at agunrunnerfilm.com . The Kensington Philadelphia Drug Market, Real Story. Attributions Facebook Wikipedia Villanovan Philadelphia City Council City Journal Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Movie Meltdown - Episode 651 (For our Patreon "Horror Club") Gather around the table with the beloved family members of the Horror Club as we celebrate Thanksgiving Jake-style. Together we discuss the state of the holiday season as well as the Thanksgiving classic Home Sweet Home starring Jake Steinfeld. And while we're trying to figure out family relations, we also cover… IT: Welcome To Derry, Doctor Sleep, Guillermo del Toro's Frankenstein, being addicted to PCP, close-up magic, Steve Guttenberg, Trapper Keeper artwork, Jacob Elordi, cutting someone's brakes for the holidays, a flexatone, hood kill, turkey-flavored Oreos, Mike Flanagan, a charming weirdo, death by smothering, Andy Muschietti, clown makeup guitar guy, warlock energy, Tryptophan, Scatman Crothers, watching surgery videos, Ready Player One, Mia Goth, running over an old lady, she's so Latin, bread in a can, Ace Frehley, Thanksgiving pizza flashbacks, dinner is not almost ready, Day of the Dead and does it come in a vial? Spoiler Alert: Full spoilers for the 1981 movie "Home Sweet Home"... you have been warned. "It's a weird world… and Jake was all up in it."

Neste episódio do Alta Definição, Paulo Raimundo é entrevistado por Daniel Oliveira, numa conversa que percorre a sua trajetória pessoal e profissional, desde a infância marcada por dificuldades económicas até à liderança política. O líder do Partido Comunista Português (PCP) partilha memórias familiares, experiências de trabalho, reflexões sobre educação, valores e desafios da vida quotidiana. Aborda ainda o impacto da sua atividade política na família, a importância da autenticidade e da luta coletiva, e destaca episódios marcantes que moldaram o seu percurso, fazendo a sua análise da realidade social portuguesa. * A sinopse deste episódio foi criada com o apoio de IA. Saiba mais sobre a aplicação de Inteligência Artificial nas Redações da Impresa ----O link para o estatudo editorial do Expresso: https://expresso.pt/sobre/estatuto-editorial/2020-01-20-estatuto-editorial-3c79f4ec O link para o estatudo editorial da SIC Notícias: https://sicnoticias.pt/institucional/2013-12-27-estatuto-editorial-sic-noticias-e84e2755 See omnystudio.com/listener for privacy information.

Veja também em youtube.com/@45_graus Zita Seabra nasceu em 1949. Foi deputada à Assembleia da República de 1975 a 1988, coordenou o Secretariado Nacional para o Audiovisual em 1993, ano em que assumiu a presidência do Instituto Português de Cinema. De 1994 a 1995, foi presidente do Instituto Português da Arte Cinematográfica e Audiovisual. É editora e autora de Foi Assim (Alêtheia, 2007), onde partilha as suas memórias desde a infância até ao momento de ruptura com o Partido Comunista Português, altura em que publicou O Nome das Coisas (Publicações Europa-América, 1988). Desde 2005, dirige a Alêtheia Editores, da qual é fundadora, assim como a Várzea da Rainha Impressores. Há longos anos no meio editorial, foi editora da Quetzal e também administradora e directora editorial da Bertrand Editora. _______________ Índice: (0:00) Introdução (2:38) Como funciona por dentro um partido comunista? | Porque dá o Comunismo sempre em totalitarismo: é da ideologia ou do tipo de pessoa que permite chegar ao poder? (14:12) Porque foi do PCP diretamente para a direita? (22:51) Posição em relação ao aborto: no PCP e depois (28:52) O 25 de novembro | Livro Álvaro Cunhal - “Rumo à Vitória” | golpe militar va insurreição militar armadaSee omnystudio.com/listener for privacy information.

Veja também em youtube.com/@45_graus Zita Seabra nasceu em 1949. Foi deputada à Assembleia da República de 1975 a 1988, coordenou o Secretariado Nacional para o Audiovisual em 1993, ano em que assumiu a presidência do Instituto Português de Cinema. De 1994 a 1995, foi presidente do Instituto Português da Arte Cinematográfica e Audiovisual. É editora e autora de Foi Assim (Alêtheia, 2007), onde partilha as suas memórias desde a infância até ao momento de ruptura com o Partido Comunista Português, altura em que publicou O Nome das Coisas (Publicações Europa-América, 1988). Desde 2005, dirige a Alêtheia Editores, da qual é fundadora, assim como a Várzea da Rainha Impressores. Há longos anos no meio editorial, foi editora da Quetzal e também administradora e directora editorial da Bertrand Editora. _______________ Índice: (0:00) Introdução (4:32) O que atrai um(a) jovem no comunismo? | Comunismo vs maoismo vs trotskismo | Os totalitarismos e os perigos do intelectualismo excessivo (26:54) Quem militava naqueles partidos sabia o que se passava na URSS e na China maoista? | Porque o comunismo deu sempre em totalitarismo? (35:42) O que a fez a primeira vez duvidar, e como saiu do PCP? | Mikhail SuslovSee omnystudio.com/listener for privacy information.

Sócrates conquistou mais vinte dias. A juíza acabou por ter de lhe dar tempo para procurar advogado. E daqui a pouco mete-se o Natal e a Passagem de Ano. O Procurador-Geral da República afirmou que o processo “Influencer” ainda não avançou porque haveria um recurso a empatá-lo no Tribunal da Relação. Resposta da Relação: não temos cá recurso nenhum. Parece que foi resolvido em Setembro e ninguém avisou o PGR. Enquanto isso, UGT e CGTP convocaram uma greve geral. Montenegro acusa as centrais sindicais de estarem ao serviço dos interesses de PS e PCP. Se quiser ver o pacote laboral aprovado no parlamento só lhe resta o Chega. E Chega não se compromete esperando para ver em que param as modas. Jiga-jogas tácticas na semana em que o giga-ministro Matias prometeu giga-fábricas em Sines e uma liderança portuguesa da inteligência artificial a nível mundial. Giga-sonhemos, então.See omnystudio.com/listener for privacy information.

Shawn Tierney meets up with Henrik Pedersen and Jacob Abel to learn about OTee Virtual PLCs in this episode of The Automation Podcast. For any links related to this episode, check out the “Show Notes” located below the video. Watch The Automation Podcast from The Automation Blog: Listen to The Automation Podcast from The Automation Blog: The Automation Podcast, Episode 252 Show Notes: Special thanks to Henrik Pedersen and Jacob Abel for coming on the show, and to OTee for sponsoring this episode so we could release it “ad free!” To learn about the topics discussed in this episode, checkout the below links: OTee Virtual PLCs website Schedule an OTee demo Connect with Henrik Pedersen Connect with Jacob Abel Read the transcript on The Automation Blog: (automatically generated) Shawn Tierney (Host): Thank you for tuning back into the automation podcast. Shawn Tierney here from Insights. And this week on the show, I meet up with Henrik Pedersen and Jacob Abel to learn all about virtual PLCs from OTee. That’s o t e e. And, I just thought it was very interesting. So if you guys have ever thought about maybe running virtual PLCs to test some processes out, I think you’ll really enjoy this. With that said, I wanna welcome to the show for the very first time, Hendrik and Jacob. Guys, before we jump into your presentation and learn more about what you do, could you first introduce yourself to our audience? Henrik Pedersen (OTee): Yeah. Sweetly. So my name is Hendrik. I am the cofounder, COO, OT, a new industrial automation company, that, we’re really glad to present here today. I have a background from ABB. I worked eleven years at ABB. In terms of education, I have an engineering degree and a master degree in industrial economics. And, yeah, I’m I’m excited to be here. Thanks, Rom. And I’ll pass it over to Jake. Jacob Abel (Edgenaut): I’m, Jacob Abel. I’m the principal automation engineer at Edgnot. EdgeNaught is a systems integrator focusing on edge computing and virtual PLCs. My background is in mechanical engineering, and I’m a professional control systems engineer, and I have thirteen years experience in the machine building side of industrial automation, specifically in oil and gas making flow separators. And I’ll hand it back to Henrik here. Henrik Pedersen (OTee): K. Great. So OT, we are a a new industrial automation company, the new kid on the block, if you will. We’re a start up. So, we only started, about three years ago now. And, we focus solely on virtual PLCs and and the data architectures allow you to integrate virtual PLCs in in operations. And, you know, some of the listeners will be very familiar with this first, thing I’m gonna say, but I think it’s valuable to just take a take a little bit step back and and remember what has happened in in history when when it comes to to IT and OT and, and and what really what really happened with that split. Right? So it was probably around the ‘9 you know, around nineteen nineties where the the the domain computer science were really split into these two domains here, the IT and OT. And, and that, that was, that was kind of natural that that happened because we got on the, on the IT side of things, we got Internet, we got open protocols and, you know, we had the personal computers and innovation could truly flourish on the IT side. But whereas on the OT side, we were we were kind of stuck still in the proprietary, hardware software lock in situation. And and that has that has really not been solved. Right? That that that is still kind of the the situation today. And it this is what this is obviously what also, brought me personally to to really got really super motivated to solve this problem and and really dive deep into it. And I experienced this firsthand with with my role in NAD and, how how extremely locked we are at creating new solutions and new innovation on the OT side. So so we’re basically a company that wants to to truly open up the the the innovation in this space and and make it possible to adopt anything new and new solutions, that that sits above the PLC and and, you know, that integrate effectively to to the controller. So I I have this this, you know, this slide that kind of illustrates this point with with some some, you know, historical events or or at least some some some big shifts that has happened. And, Aurene mentioned a shift in nineteen nineties. And it wasn’t actually until ’20, 2006 that Gartner coined this term OT, to explain the difference really what what has happened. And and, you know, as we know, IT has just boomed with innovation since since the nineties and OT is, is, is slowly, slowly incrementally getting better, but it’s still, it’s still the innovation pace is really not, not fast. So, this is also, of course, illustrated with all the new developments in in GenAI and AgenTic AI, MCP, and things like that that is kinda booming on on the IT side of things. And and and yeah. So, but we do believe that there is actually something happening right now. And and we have data that they’re gonna show for for that. Like, the the large incumbents are now working on this as well, like virtual PLCs, software defined automation and all kinds of exciting things going on on the OT side. So we do believe that that we will see, we will see a shift, a true big shift on the OT side in terms of innovation, really the speed in which we can, we can improve and adopt new solutions on the OT side. And this is kind of exemplified by, like, what what is the endgame here? Like, you could say that the endgame could be that IT and OT once once again becomes the same high paced innovation domain. Right. But then we need to solve those underlying problems, the infrastructural problems that are still so persistent on the OT side of things. The fine point of this slide is to just illustrate what’s happening right now. It’s like cloud solutions for control is actually happening. Virtual PLC, software based automation, AI is happening all at once. And we see it with the big suppliers and and also the exciting startups that’s coming into this space. So I think there’s there’s lots of great excitement now that we can we can expect from the OT side, in in next few years. Shawn Tierney (Host): Yeah. You know, I wanna just, just for those listening, add a little, context here. If we look at 1980, why was that so important? Why is this on the chart? And if you think about it, right, we got networks like Modbus and, Data Highway in nineteen seventy eight, seventy nine, eighty. We also got Ethernet at that time as well. And so we had on the plant floor field buses for our controls, but in the offices, people were going to Ethernet. And then when we started seeing the birth of the public Internet, right, we’re talking about in the nineties, people who are working on the plant floor, they were like, no. Don’t let the whole world access by plant floor network. And so I think that’s where we saw the initial the the divide, you know, was 1980. It was a physical divide, just physically different topologies. Right? Different needs. Right? And then and and as the Internet came out in the early nineties, it was it was now like, hey. We need to keep us safe. We know there’s something called hackers on the Internet. And and I think that’s why, as you’re saying in 2006, when Gartner, you know, coined OT, we were seeing that there was this hesitant to bring the two together because of the different viewpoints and the the different needs of both systems. So I think it’s very interesting. I know you listeners, you can’t see this, but I kinda want to go back through that and kinda give some context to those early years. And and, you know, like Henrik says, you know, now that we’re past all that, now that we’re using Ethernet on the plant floor everywhere, right, almost everywhere, on all new systems, definitely, that that becomes the right now on this on the today on the, on the chart. And I’ll turn it back to you, Henrik. Henrik Pedersen (OTee): Yeah. I’ll search that. I just wanna echo that as I think that there are really good reasons for why this has happened. Like, the there has you could argue that innovation could flourish on the IT side because there was less critical systems, right, less, more, you know, you can do to fail fast and you can do, you can test out things on a different level. And so so there’s really lots of good reasons for why this has happened. We do believe that right now there is some really excitement around innovation, the OT side of things and and this pent up kind of, I wouldn’t call it frustration, but this pent up potential, I think is the right word, is is can be kind of unleashed in our industry for for the next, next decade. So so we are like this is really one of the key motivators for me personally. It’s, like, I truly believe there’s something truly big going on right now. And and I I do I do encourage everyone, everyone listening, like, get in get in on this. Like, this is happening. And, you know, be an entrepreneur as well. Like, build your company, build and, you know, create something new and exciting in this space. I think I think this is this is a time that there hasn’t been a better time to create a new new technology company or a new service company in this space. So this this, this is something at least that motivates me personally a lot. So let me move over to kind of what we do. I mentioned I mentioned that we focus solely on the virtual PLC. This this is now presented in the slide for those that are listening as a as a box inside a open hardware. We can deploy a virtual PLC on any, ARM thirty two thirty two and and sixty four bit processor and x eighty six sixty four bit with the Linux kernel. So so there are lots of great, options to choose from on the hardware side. And and, and yeah. So you can obviously when you have a Virtual PLC you can think of it new in terms of your system architecture. You could for instance, you know deploy multiple Virtual PLCs on this on the same hardware and you can also, think about it like you can use a virtual PLC in combination with your existing PLCs and could work as a master PLC or some kind of optimization deterministic controller. So it’s it’s really just opening up that, you know, that architectural aspect of things. Like you can think new in terms of your system architecture, and you have a wide range of hardware to choose from. And, and yeah, So the the flexibility is really the key here, flexibility in how you architect your system. That CPU that you deploy on will will obviously be need to be connected to to the field somehow, and that’s that’s true, classical remote IO, connections. So we currently support, Modbus TCP and Ethernet IP, which is kind of deployed to to, our production environment, as it’s called. So moving on to the next slide. Like, this is kind of the summary of our solution. We have built a cloud native IDE. So meaning anyone can can basically go to our website and log in to into the solution and and give it a spin. And, we’ll show you that afterwards with with Jake. And the system interacts through a PubSub data framework. We use a specific technology called NUTS, for the PubSub communication bus. And you can add MQTT or OPC UA to the PubSub framework, according to your needs. So, and from that, you can integrate with, whatever whatever other, software you might have, in your system. So we have these value points that we always like to bring up. Like, this obviously breaks some kind of vendor lock in in terms of the hardware and the software. But it’s also, our virtual PLC is based on on the six eleven thirty one. So it’s not a lock in to any kind of proprietary programming language or anything like that. There is, there’s obviously the cost, element to this that you can potentially save a lot of cost. We have, we have verified with with with some of our customers that they estimate to save up to 60% in total cost of ownership. This is there is obviously one part is the capex side and the other part is is the opex. And and is this data framework, as I mentioned, is in in in which itself is is future proof to some extent. You can you can integrate whatever comes comes in in a year or or in a few years down the line. And, there’s environmental footprint argument for this as you can save a lot on the on the infrastructure side. We have one specific customer that estimates to save a lot on and this this particular point is really important for them. And then final two points is essentially that we have built in a zero trust based security, principle into this solution. So we have role based access control. Everything is encrypted end to end, automatic certification, and things like that. The final point is, is that this is the infrastructure that allows you to bring AI and the classical, DevOps, the the thing that we’re very used to in the IT side of things. Like, you you commit and merge and release, instead of, instead of the traditional, way of working with your automation systems. So I know this is like, this is pro pretty much, like, the boring, sales pitch slide, but, but, yeah, I just wanted to throw this this out there for for the guys that there is some there is some, intrinsic values underneath here. The way the system works, you will you will see this very soon, through the demo, but it’s basically you just go to a website, you log in, you create a project. In there, you would create your your PLC program, test, you code, you simulate. You would onboard a device. So onboard that Linux device that you you want to deploy on. This can be as simple as a Raspberry Pi, or it can be something much more industrial grade. This depends on on on the use case. And then you would deploy services like, as I mentioned, MQTT and OPC UA, and then you would manage your your your system from from the interface. And, I have this nice quote that we got to use from one of the customers we had. This is a global, automotive manufacturer that, basically tells us that it’s, they they highlighted the speed in which you can set this up, as as one of the biggest values for them, saving them a lot of hours and setting setting up the system. So I also wanted to show you a real you know, this is a actual real deployment. It was it was deployed about a year ago, and this is a pump station, or a water and wastewater operator with around 200 pump stations. They had a mix of of Rockwell and Schneider PLCs, and they had a very high upkeep, and they were losing a lot of data from these stations because they were connected over four g. When the Internet was a bit poor, they lost a bit of data in their SCADA systems, so they had these data gaps and things like that. So pretty pretty, you know, standard legacy setup to be to be honest. Quite outdated PLCs as well. So what they what they did for the first, pump station was they they, you know, removed the PLC. They put in a Raspberry Pi for for, like, €60 or, like, $70, connected it to to a to a remote IO Ethernet IP module they had, in in the storage, and deploy this data framework as I’m showing on the screen now. So so they that was that was the first station they put online, and they they chose a Raspberry Pi because they thought, okay, this is interesting, but will it work? And then they chose a pump station, which was was really just poor from before. So they had very little to to to lose to to deploy on this station. So so, yeah, this has been running for a year now without any any problems on a Raspberry Pi. We have obviously advised against using a Raspberry Pi in a critical environment, but they just insisted that that what that’s what they wanted to do for this first case. Shawn Tierney (Host): And I’ll back that up too. Your generic off the shelf Raspberry Pi is just like a generic off the shelf computer. It’s not rated for these type of environments. Not that all pump houses are really bad, but they’re not air conditioned. And I think we’ve all had that situation when it’s a 120, 130 out that, you know, off the shelf computer components can act wonky as well as when they get below freezing. So just wanted to chime in there and agree with you on that. For testing, it’s great. But if you’re gonna leave it in there, if you were in my town and you say you’re gonna leave that in there permanently, I would ask to have you, assigned somewhere else for the town. Henrik Pedersen (OTee): Yeah. Yeah. Exactly. No. So and and that point is also illustrated with the second station they brought online. So there they chose a much more industrial grade CPU, that, that, was much, you know, cost cost a bit more, but it’s more suited for the environment. And, and yeah. So this was, I can disclose it was a Bayer Electronics, CPU. So so yeah. And, and they reported, some good, good metrics in terms of, like, the results. They they said around 50 on the hardware, 75% on the management of the PLC system. So this relates more to that they have very a lot of, you know, driving out with the car to these stations and doing changes to their systems and, and updates. They no longer have any, any data loss. It’s local buffer on the data framework. They’ve increased tag capacity with 15 x, resulting in in four fifty five x better data resolution and a faster scan frequency. And this is actually on the Raspberry Pi. So so just just think of it as as the the even the even the, kind of the lowest quality IT off the shelf, computers, are are able to to, to execute really fast in in in, or fast enough for for, for these cases. So, Shawn, that was actually what I wanted to say. And, and also, you know, yeah, we are we are a start up, but we do have, fifth users now in 57 different countries across the world. And it’s it’s really cool to see our our our, our technology being deployed around the world. And, and yeah. I’m really, really excited to to, to get more, users in and and hear what they what they, think of the solution. So so yeah. I’ll I’ll with that, I don’t know if, Shawn, you wanna you shoot any questions or if we should hand it over to Jake for for for a demo. Shawn Tierney (Host): Yeah. Just before we go to Jake, if somebody who’s listening is interested, this might be a good time. It said that, you already talked about being cloud based. It’s, o t e e. So Oscar Tom, Edward Edward for the the name of the company. Where would they go if if they like what Jake’s gonna show us next? Where will they go to find out more? Henrik Pedersen (OTee): Yeah. So I would honestly propose that they just, reach out to to me or Jake, on on one of the QR codes that we have on the presentation. But they can also obviously go to our website, 0t.io,0tee.io, and just, either just, log in and test the product, or they could reach out to us, through our website, through the contact form. So yeah. Shawn Tierney (Host): Perfect. Perfect. Alright, Jake. I’ll turn it over to you. Jacob Abel (Edgenaut): Thanks, Shawn. Fantastic stuff, Henrik. I wanna take a second too to kinda emphasize some of the technical points that you, presented on. Now first, the the fact that you have the built in zero trust cybersecurity is so huge. So, I mean, the OT cybersecurity is blowing up right now. So many certifications, you know, lots of, consulting and buzz on LinkedIn. I mean, it’s a very real concern. It’s for a good reason. Right? But with this, zero trust built in to the system, I I mean, you can completely close-up the firewall except for one outgoing port. And you have all the virtual PLCs connected together and it’s all done. You know, there’s no incoming ports to open up on the firewall to worry about, you know, that security concern. You know, it’s basically like, you know, you’ve already set up a VPN server, if you will. It’s it’s not the same, but similar and, you know, taking care of that connection already. So there’s an immense value in that, I think. Shawn Tierney (Host): And I wanted to add to the zero trust. We’ve covered it on the show. And just for people, maybe you’ve missed it. You know, with zero trust is you’re not trusting anyone. You authorize connections. Okay? So by default, nobody’s laptop or cell phone or tablet can talk to anything. You authorize, hey. I want this SCADA system to talk to this PLC. I want this PLC to talk to this IO. I want this historian to talk to this PLC. Every connection has to be implicitly I’m sorry. Explicitly, enabled and trusted. And so by default, you know, an an integrator comes into the plant, he can’t do anything because in a zero trust system, somebody has to give him and his laptop access and access to specific things. Maybe he only gets access to the PLC, and that makes sense. Think about it. Who knows whether his laptop has been? I mean, we’ve heard about people plug in to the USB ports of the airport and getting viruses. So it’s important that person’s device or a SCADA system or a historian only has access to exactly what it needs access to. Just like you don’t let the secretary walk on the plant floor and start running the machine. Right? So it’s a it’s an important concept. We’ve covered it a lot. And and, Jake, I really appreciate you bringing that up because zero trust is so huge, and I think it’s huge for OT to have it built into their system. Henrik Pedersen (OTee): Yeah. Absolutely. Absolutely. Jacob Abel (Edgenaut): I wanted to highlight too the Henrik mentioned that the the backbone of the system is running on a technology called NATS. That’s spelled n a t s. And why that’s important is this is a a lightweight messaging, service, and it’s designed to send millions of messages per second. You know, that’s opposed to, you know, probably the best Modbus TCP device that you can find. You might get a couple 100 messages through per second. It’s millions of messages per second. It’s, you know, especially with, you know, we’re dealing with AI machine learning, you know, training models. I mean, we’re data hungry. Right? So this gives you the backbone too. You know, it’s like it can push an immense amount of tag data, you know, with ease. I think that’s another really important point. With that, though, I’ll I’ll get on to the demo. Henrik Pedersen (OTee): Oh, that’s great. We do we do see that, Jay, that most of our customers report on that, you know, 400 or 700 x better data resolution. And so it’s it’s a step change for for for the data resolution there. Yeah. Jacob Abel (Edgenaut): Excellent. So one of the things that I personally love about OT is how quickly you can get into the PLC once everything’s set up. So this is OT’s website, obviously, ot.io. So once you’re here, you just go to log in. And that brings in the login screen. Now I’m are I’m using my Google account for single sign on, so I can just click continue with Google. And this brings me into the main interface. And another thing that I love is that, you know, it is very simple and straightforward, you know, and simple is not a bad thing. Simple is a good thing. I mean, the way that things should be is that it should be, it should be easy and the finer details are taken care of for you. So right here, we have our main project list. I just have this one benchmarking program that I’ve imported in here. And you also have device lists, just a a test device that I’ve installed the runtime on. Just real quick. You know, you have a Martha, the AI assistant in the corner here. And, the documentation guides is up here. So you can get help or look into reference material very easily. It’s all right there for you. So I’m gonna open up this program here. So just a quick tour here. Right up here in the top left is basically where where most everything’s done. So if you click on this little down arrow, you can choose what virtual PLC runtime to attach it to. I’ve already attached it to the device. I installed the runtime on. You can add, you know, a new program, driver, function blocks, custom data types real quick here. Compile your program, download it to the device. Check the release history, which is really, really great. As you can, you can go into release history and you can revert to a prior version very easily. We got built in, version control, which is another, great feature. Henrik Pedersen (OTee): I can also just comment on that, Jake, that we do have we do have, in the quite short term roadmap to also expand on that with Git integration, that, a lot of our customers are are asking for. So yeah. Jacob Abel (Edgenaut): Awesome. Yeah. I mean, that’s that’s another, very hot topic right now. It’s, you know, getting getting the revision control systems, as part of, you know, at least the textual, programming languages. See, so, you know, we have a few, like, housekeeping things here. I mean, you can delete the program, export it. It’s a good good point here is that, OT complies with the PLC open, XML specification. So you can import or export programs, in this XML format, and it should work with solid majority of other automation software out there. You know, if you need to, you want to transition over to OT, you know, you can export it from your other software and import it rather easily. Got your program list here and, you know, just the basic configuration of, you know, you can add global variables that you wanna share between the different programs and POUs or, you know, change the, cycle rate of the periodic tasks, add more tasks. Let’s just get jump into this program here. Both the system uses the IEC sixty one one thirty one dash three standard structured text. So here’s just a little, quick benchmark program that I’ve been using to do some performance testing. Like you, you have the, the code right here, obviously. And on our, our right, the variable list, very easy to add a new variable and pick out the type. You can set a set of default value, add some notes to it. Super easy. So let’s go online. So if you have these little glasses up here in the top, right, you display live tag values. And so it’s grabbing from the runtime that’s running and plopping it right in here in the editor, which I I love the way it’s displayed. It makes it. And, you know, it’s one of the question marks is if you’re doing structured text instead of letter logic, like how it’s gonna show up and how readable is it gonna be. I think the, the text, like the color contrast here helps a lot. It’s very, very readable and intuitive. And we also have the tag browser on the right hand side. Everything is, organized into, you know, different groups. There’s the the resources and instances that you’ve set up in the configuration tab. So the by default, the tag the tags are all listed under there. And here too, you know, you can set tag values doing some performance testing, as I said. So this is, recording some some jitter and task time metrics. And that’s that’s really it. That’s the that’s the cloud IV in a nutshell. Super easy, very intuitive. I mean, it’s there there’s zero learning curve here. Shawn Tierney (Host): For the, audio audience, just a little comment here. First of all, structured text to me seems to be, like, the most compatible between all PLCs. So, you know, everybody does ladder a little bit differently. Everybody does function blocks a little bit differently. But structured text and, again, I could be wrong if you guys think out there in the in listening, think I’m wrong about that. But when I’ve seen structured text and compared it between multiple different vendors, it always seems to be the closest from vendor to vendor to vendor. So I can see this makes a great a great place to start for OT to have a virtual PLC that supports that because you’re gonna be able to import or export to your maybe your physical PLCs. The other thing is I wanted to comment on what we’re seeing here. So, many of you who are familiar with structured text, you know, you may have an if then else, or an if then. And and you may have, like, tag x, equals, you know, either some kind of calculation, you know, maybe, you know, z times y or just maybe a a constant. But what we’re seeing here is as we’re running, they have inserted at a in a different color the actual value of, let’s say, tag x. So in between you know, right next to tag x, we see the actual value changing and updating a few times a second. And so it makes it very easy to kinda monitor this thing while it’s running and see how everything’s working, and I know that’s that’s huge. And I know a lot of vendors also do this as well, but I love the integration here, how it’s so easy to see what the current values are for each of these variables. And, I’ll turn it over to you, Hendrick. I think I interrupted you. Go ahead. Henrik Pedersen (OTee): Yeah. No. I was just gonna comment on that. Jake said, like, this is the this is the POC editor, and the next the next big feature that we’re releasing very soon is essentially the service, manager, which is the, which is the feature that will allow our users to deploy any kind of service very efficiently, like another runtime or OPC UA server or an entity server or or or whatever other, software components that that, you want to deploy, like a Knox server or things like that. So and that’s that’s, we were really excited about that because, that will kind of allow for a step change in how you kind of orchestrate and manage your system and your, your system and your, your, you have a very good overview of what’s going on with versions of, of the different software components running in your, your infrastructure and your devices and things like that. So we’re really excited about that, that it’s coming out. And it might be that actually when when this, episode airs, who knows if it’s if it’s done or or not, but we’re very close to release the first version of that. So excited about that. Shawn Tierney (Host): Now I have a question for you guys, and maybe this is off topic a little bit. So let’s say I’m up here in the cloud. I’m working on a program, and I have some IO on my desk I wanna connect it to. Is that something I can do? Is there a connector I can download and install my PC to allow the cloud to talk to my IO? Or is that something where I have to get a a, you know, a local, you know, like we talked about those industrial Linux boxes and and test it here with that? Henrik Pedersen (OTee): Yeah. So I think you what you what you’re you’re after is, like, the IO configuration of, if you wanna deploy a driver, right, or, like, a modbus driver and how you figure out the system. Right? Shawn Tierney (Host): Yeah. Because this is in the cloud. It’s not on my desk. The IO is on my desk. So how would I connect the two of them? How would I is is that something that can be done? Henrik Pedersen (OTee): Yep. Yeah. Exactly. That’s that’s actually the you know, I I think, Jake, you might just wanna show why you deploy a driver. Right? Jacob Abel (Edgenaut): Sure. Sure. And I just wanna take a second to, clarify. You know, it’s something that kinda comes up often, and I I don’t I don’t think it gets it’s it’s cleared up enough is that so, you know, we have this cloud ID here. So, you know, you can open this from anywhere in the world. But the virtual PLC run times get installed on computers preferably very locally, you know, on the machine, on the factory floor, something like that. I I’ve got, an edge computer right here. Just as an example. I mean, this is something you would just pop in the control panel and you can install OT on this. So to answer your question better, Shawn, you know, to get to, you know, the remote IO that you need essentially, or actually in the, in the case of this, this has onboard IO. You know, you’re looking at connecting with MOBAs, PCP, Ethernet IP. I I know that a lot more protocols are coming. Profinet. So how you would do that is that you have that plus sign up here and add a driver config. We’re just gonna do, Modbus real quick. Henrik Pedersen (OTee): Mhmm. Jacob Abel (Edgenaut): And we wanna add a TCP client. So you can name the client, tell it how fast to pull, you know, any delays, put in the IP address. Just an example. Do the port number if you need and then add your requests. You know, you have support for, all the main function codes and mod bus right here, you know, read holding, read input, you know, write multiple coils, all that good stuff, you know, tell address how many registers you wanna do, timeouts, slave ID. And then, you know, once you’ve done that, so let’s say, you know, I’m gonna read, and holding registers here, the table on the right auto updates. You can do aliases for each one of these. You can just do register one Mhmm. As an example Shawn Tierney (Host): It’s showing just for the audio audience, it’s showing the absolute address for all these modbus, variables and then, has the symbols, and he’s putting in his own symbol name. It has a default symbol name of symbol dash something, and he’s putting his own in, like, register one, which makes it easier. Yeah. Jacob Abel (Edgenaut): Good point. Yeah. Good point. Thanks, Shawn. So, yeah, once once you put in your request and you can throw in some aliases, for the different registers, you know, you can go back to your program and here’s this, sample variable that I just added from earlier. You know, you can the registers are 16 bits. I’m gonna select, an int. And what you can do here now is select those modbus requests that you just set up. So it automatically maps these to those variables for you. So that that way you don’t have to do anything anything manual, like have a separate program to say, you know, this tag equals, you know, register 40,001. You know, it’s already mapped for you. So that’s that’s essentially how you would connect to remote IO is, just add a client in the driver configs and, fill in all your info and be off and running. Shawn Tierney (Host): That’s excellent. I really liked how you were able to easily map the register to the modbus value you’re reading in or writing to to your, variable so you can use that in your program. That was very easy to do. Jacob Abel (Edgenaut): Oh, yeah. Yeah. It’s that it’s like I said, that’s one of the things that I love about this interface is that everything is just very straightforward. You know, it’s it’s super easy to just stumble upon whatever it is you need and figure it out. Henrik Pedersen (OTee): And just just, to add to to kinda your your processors, like, once you have created that connection between the IO and and and the program, you basically just, compile it and download it to the to the runtime again, and and it executes locally the based on the yeah. Nice. Jacob Abel (Edgenaut): Oh, right. Good point. Yeah. Of of course, after we add something, we do have to redownload. So Shawn Tierney (Host): Very interesting. Well, that answers my question. Jacob Abel (Edgenaut): I think that’s that’s about it for the the demo. I mean, unless, Shawn, you have any more questions about the interface here. Shawn Tierney (Host): No. It looked pretty straightforward to me, Hendrik. I don’t know. Did you have anything else you wanted to discuss while we have the demo up? Henrik Pedersen (OTee): Nope. Not nothing related to this except for that, you know, this is probably something that’s quite new in the OT space is that this is a software service, meaning that there are continuous development going on and releases, and improvements to the software all the time. Like literally every week we deploy new improvements. And, and what, I typically say is that like, the, you know, if you if you if you sign up with OT, what you what you will experience is that the actual software keeps on becoming better over time and not is not going to become outdated. It’s going to be just better over time. And I think that’s part of what I really loved about the innovation space, innovation happening around IT is that that, that has become the new de facto standard in how you develop software and great software. And I think we in, in, in the OT space, we need to adopt that same methodology of developing software, something that continuously becomes better over time. Shawn Tierney (Host): Yeah. And I would just say, you know, if you’re if you’re on the OT side of things, you wanna be in six eleven thirty one dash three languages, because these are things that your staff, you know, what you know, your electricians and technicians and even engineers, you know, should know, should be getting up to speed. I don’t know. We’re at the automation school. We’re teaching, structured text. And so, easier. I look at this, and I’m like, this is a lot easier than trying to learn c plus or or JavaScript. So in any case, I think, you know, if it’s an OT side real IO control, real control system or data collection, you know, you know, very important, you know, mission critical data collection, then, you know, I’d rather have this than somebody trying to write some custom code for me and, you know, use some kind of computer language who doesn’t understand, you know, the OT side of things. So, I could definitely see the advantage of your system, Henrik. Henrik Pedersen (OTee): Yep. I I I also wanted to say to that, Stike, the I I do not believe the EIC standards in general will disappear. They exist for a very good reason. Right. Exists to standardise to to ensure safety and determinists, determinism in this. So I don’t think they will disappear. But there are obviously advances now with AI and things like that that can can help us create these things much faster and much more efficient and things like that. So, so but, but the EIC standards, I think, will be there for a very long time. Obviously, the 06/4099 standard is is really exciting, and and we believe that that can be, yeah, that that can clearly be there, but it’s still a new EIC standard. So, Shawn Tierney (Host): it’s not think what we’re gonna see is we’re gonna see a lot more libraries fleshed out. There’ll be a lot less writing from scratch. We’ve interviewed on the History of Automation podcast. We’ve interviewed some big integrators, and they’re at a point now, you know, twenty, thirty years on that they have libraries for everything. And I think that’s where we’ll see, you know, much like the DCS, I think, vendors went two years ago. But I still think that the there’s a reason for these languages. There’s a reason to be able to edit things while they run. There’s a reason for different languages for different applications and different, people maintaining them. So I agree with you on that. I don’t I don’t think we’re we’re gonna see the end of these, these standard languages that have done us very well since the, you know, nineteen seventies. Jacob Abel (Edgenaut): I just wanna add a bit on there about, Shawn, you mentioned, you know, doing less code. I I did show earlier in the bottom right hand corner here, we have our our little AI assistant, Martha. I don’t believe the feature, it has been released yet. You know, Henrik, correct me if I’m wrong, but I know one of the things that’s coming is, AI code generation, you know, similar to that of cloud or chat GPT. So it’s going to, you know, you can open this guy up here. You know, right right now, I think it’s just for, help topics, but you’ll be able to talk to Martha and she’s gonna generate code for you in your program there all built in. Henrik Pedersen (OTee): Yeah. Yeah. That’s that’s coming really fast now. So, it’s it’s not been implemented yet, but it’s, it’s right around the corner. Shawn Tierney (Host): Yeah. And it’s it’s not gonna be able to it’s you’re not gonna be able to hook a camera up to it and, like, take pictures of your machine and say, okay. Write the control code for this. But, you know, if you had a, you know, process that had 12 steps in it, the AI could definitely help you generate that code and and other code. And we’ll have to have Henrik and Jake back on to talk about that when it comes out, but, you know, it’s gonna be able to save you, reduce the tedious part of the the coding. You know, if you need an array of so many tags and so many dimensions or, you know, the stuff that, you know, it would just be the typing intensive, it’s gonna be able to help you with that, and then you can actually put the context in there. Just like, you can pull up a template in Word for a letter, and then you can fill in the blanks. You know? And and, of course, AI is helping make that easier too. But, in any case, Henrik, maybe you can come back on when that feature launches. Henrik Pedersen (OTee): Yeah. Absolutely. And I’m also excited about just a simple a use case of of translating something. Right? Translating your existing let’s say if it’s a proprietary code or something like that, like, getting it getting it standardized and translating it to the ESE six eleven thirty one standard, for instance, or, so so the obviously AI is, like, perfect for this space. It’s there is no doubt, And and it’s, like, that’s also why I’m so excited about, like, what’s going on at the moment. It’s like there’s so much innovation potential, in the on the OT side now that, they are with all these new technologies. Shawn Tierney (Host): Yeah. Absolutely. Absolutely. Well, gentlemen, was there anything else you wanted to cover? Henrik Pedersen (OTee): I think just just one final thing from from me is, like, we thought a lot about it, like, before this this episode, and we thought, like, let’s offer let’s offer the listeners something something of of true value. So so we thought, the, you know, after this after this episode launched, we want to want to offer anyone out there that’s listening a free, completely hands on trial of our technology, in their in their in their environment or on their Raspberry Pi or whatever. So just just reach out to us if you wanna do that. And, and I yeah. We’ll get you set up for for for testing this, and it’s not gonna cost you anything. Shawn Tierney (Host): Well, that’s great. And, guys, if you’re listening, if you do take advantage of that free trial, please let me know what you thought about it. But, Henrik, thank you so much for, that offer to our listening audience. Guys, don’t be bashful. Reach out to him. Reach out to Jake. Jake, thank you for doing the demo as well. Really appreciate it. My pleasure. Any final words, Henrik, before we close out? Henrik Pedersen (OTee): No. It’s been great. Great, being here, Shawn, and thanks for for helping us. Shawn Tierney (Host): Well, I hope you enjoyed that episode. I wanna thank Hendrik and Jacob for coming on the show, telling us all about OT virtual PLCs, and then giving us a demo. I thought it was really cool. Now if any of you guys take them up on their free trial, please let me know what you think. I’d love to hear from you. And, with that, I do wanna thank OT for sponsoring this episode so we could release it completely ad free. And I also wanna thank you for tuning back in this week. We have another podcast coming out next week. It’ll be early because I will be traveling and doing an event with a vendor. And so expect that instead of coming out on Wednesday to come out on Monday if all goes as planned. And then we will be skipping the Thanksgiving, week, and then we’ll be back in the in the, in December, and then we have shows lined up for the new year already as well. So thank you for being a listener, a viewer, and, please, wherever you’re consuming the show, whether it’s on YouTube or on the automation blog or at iTunes or Spotify or Google Podcasts or anywhere, please give us a thumbs up and a like or a five star review because that really helps us expand our audience and find new vendors to come on the show. And with that, I’m gonna end by wishing you good health and happiness. And until next time, my friends, peace. Until next time, Peace ✌️  If you enjoyed this content, please give it a Like, and consider Sharing a link to it as that is the best way for us to grow our audience, which in turn allows us to produce more content

(00:00-17:49) If you see Tim out and about on trashed Tuesday, just celebrate in silence. Not sure there's a fit with Kyrou and the Maple Leafs right now. Jackson is responding through drops. Tim wants 364 designated as the best road in all of St. Louis. STOP TELLING PEOPLE ABOUT 364. Jackson loves autumnal drives and fall sunsets. PCP's got a nice ass. Getting deported from Cottleville.(17:57-19:56) Continuing the horny music theme.(20:06-35:46) Doug, what about that Fiona Apple? How do tornados work? We respect golf course employees and their airhorns. Audio of Danny Kanell saying he's done with a G5 team getting an autobid into the College Football Playoffs. The five-seed is the sweet spot to be in for the CFP. Is Lex Luthor playing a character? Jackson was the first to announce the Brian Daboll firing.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Put on your flotation devices and keep an eye on the catering table, because today, we're getting a broader understanding of what happened on the set of Titanic when around 80 cast and crew members were drugged with PCP on the last night of filming in Nova Scotia Become a supporter of this podcast: https://www.spreaker.com/podcast/broads-next-door--5803223/support.

Explore how GLP-1 meds can help or harm eating disorders with Dr. Laura Bridge When weight-loss meds meet eating disorders: GLP-1 drugs are reshaping medicine,  but could they also be fueling disordered eating? Join Dr. Laura Bridge as we unpack the risks, red flags, and how to keep “healthy” from turning harmful.  Also, how to approach restrictive eating disorders, bulimia, and binge eating disorder as a PCP. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Introduction Defining Eating Disorders  Screening & Permission to Discuss  Clinical Approach & History Gathering  Treatment Framework  GLP-1 Contraindications Dr. Bridge's Take-Home Points  Credits Producer, writer, show notes, cover art and infographics: Isabel Valdez, PA-C Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Molly Heublein MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Laura Bridge MD, FACP Disclosures Dr. Laura Bridge no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.  Sponsor: Locumstory Learn about locums and get insights from real-life physicians, PAs and NPs at Locumstory.com. Sponsor: Panacea Legal  Panacea Legal is giving Curbsiders listeners one more reason to feel thankful with 50% off any contract review service by using promo code CURB50. But hurry, this offer is only available for the first 10 doctors who use the code. Visit Panacea.Legal today Sponsor: Hydrow  Head over to Hydrow.com and use code CURB to save up to $600 off on Hydrow rower during this holiday season.  Sponsor: Grammarly  Visit Grammarly.com/podcast and Sign up for FREE

Dr. Pedro Barata and Dr. Aditya Bagrodia discuss the evolving landscape of testicular cancer survivorship, the impact of treatment-related complications, and management strategies to optimize long-term outcomes and quality of life. TRANSCRIPT:  Dr. Pedro Barata: Hello and welcome to By the Book, a podcast series from ASCO that features engaging conversations between editors and authors of the ASCO Educational Book. I'm Dr. Pedro Barata. I'm a medical oncologist at University Hospitals Seidman Cancer Center and associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also an associate editor of the ASCO Educational Book. We all know that testicular cancer is a rare but highly curable malignancy that mainly affects young men. Multimodal advances in therapy have resulted in excellent cancer specific survival, but testicular cancer survivors face significant long term treatment related toxicities which affect their quality of life and require surveillance and management. With that, I'm very happy today to be joined by Dr. Aditya Bagrodia, a urologic oncologist, professor, and the GU Disease Team lead at UC San Diego[KI1]  Health, and also the lead author of the recently published paper in the ASCO Educational Book titled, "Key Updates in Testicular Cancer: Optimizing Survivorship and Survival." And he's also the host of the world-renowned BackTable Urology Podcast. Dr. Bagrodia, I'm so happy that you're joining us today. Welcome. Dr. Aditya Bagrodia: Thanks, Pedro. Absolutely a pleasure to be here. Really appreciate the opportunity. Dr. Pedro Barata: Absolutely.  So, just to say that our full disclosures are available in the transcript of this episode.  Let's get things started. I'm really excited to talk about this. I'm biased, I do treat testicular cancer among other GU malignancies and so it's a really, really important topic that we face every day, right? Fortunately, for most of these patients, we're able to cure them. But it always comes up the question, "What now? You know, scans, management, cardio oncology, what survivorship programs we have in place? Are we addressing the different survivorship piece, psychology, fertility, et cetera?" So, we'll try to capture all of that today. Aditya, congrats again, you did a fantastic job putting together the insights and thoughts and what we know today about this important topic. And so, let's get focused specifically about what happens when patients get cured. So, many of us, in many centers, were fortunate enough to have these survivorship programs together, but I find that sometimes from talking to colleagues, they're not exactly the same thing and they don't mean the same thing to different people, to different institutions, right? So, first things first. What do you tell a patient perhaps when they ask you, "What can happen to me now that I'm done with treatment for testicular cancer?" Whether it's chemotherapy or just surgery or even radiation therapy? "So, what about the long term? What should I expect, Doctor, that might happen to me in the long run?" Dr. Aditya Bagrodia: Totally. I mean, I think that question's really front and center, Pedro, and really appreciate you all highlighting this topic. It was an absolute honor to work with true thought leaders and the survivorship bit of it is front and center, in my opinion. It's really the focus, you know, we, generally speaking should be able to cure these young men, but it's the 10, 15, 20 years down the way that they're going to largely contend with. The conversation really begins at diagnosis, pre-education. Fortunately, the bulk of patients that present are those with stage one disease, and even very basic things like before orchiectomy, talking about a prosthetic; we know that that can impact body image and self esteem, whether or not they decide to receive it or not. Actually, just being offered a prosthetic is important and this is something, you know, for any urologist, it's kind of critical. To discussing fertility elements to this, taking your time to examine the contralateral testicle, ask about fertility problems, issues, concerns, offer sperm banking, even in the context of a completely normal contralateral testicle, I think these things are quite important.  So if it's somebody with stage one disease, you know, without going too far down discussing adjuvant therapy and so forth, I will start the conversation with, "You know, the testes do largely two things. They make testosterone and they make sperm." By and large, patients are going to be able to have acceptable levels of testosterone, adequate sperm parameters to maintain kind of a normal gonadal state and to naturally conceive, should that be something they're interested in. However, there's still going to be, depending on what resource you look at, somewhere in the order of 10-30% that are going to have issues. Where I think for the stage one patients, it's really incumbent upon us is actually to not wait for them to discuss their concerns, particularly with testosterone, which many times can be a little bit vague, but to proactively ask about it every time. Libido, erectile quality, muscle mass maintenance, energy, fatigue. All of these are kind of associated symptoms of hypogonadism. But for a lot of kids 18-20 years old, it's going to be something insidious that they don't think about. So, for the stage one patients, it absolutely starts with gonadal function. If they are stage two getting surgery, I think the counseling really needs to center around a possibility for ejaculatory dysfunction. Now, for a chemotherapy-naive, nerve-sparing RPLND, generally these days we should be able to preserve ejaculatory function at high volume centers, but you still want to bring that up and again kind of touch base on thinking about sperm banking and so forth before the operation, scars, those are things I think worth talking about, small risk of ascites. Then, I think the intensity of potential long term adverse effects really ramps up when we're talking about systemic therapy, chemotherapy. And then there's of course some radiation therapy specific elements that come up. So, for the chemotherapy bits of it, I really think this is going to be something that can be a complete multi-system affected intervention. So, anxiety, depression, our group has actually shown using some population resources that even suicidality can be increased among patients that have been treated for germ cell tumor. You know, really from the top down, tinnitus, hearing changes, those are things that we need to ask about at every appointment. Neuropathy, sexual health, that we kind of talked about, including ED (erectile dysfunction), vertigo, dizziness, Raynaud's phenomenon, these are kind of more the symptoms that I think we need to inquire about every time. And what we do here and I think at a lot of survivorship programs is use kind of a battery of validated instruments, germ cell tumor specific, platinum treated patient specific. So we use a combination of EORTC questions and PROMIS questions, which actually serves as like a review of systems for the patient, also as a research element. We review that and then depending on what might be going on, we can dig into that further, get them over to colleagues in audiology or psychology, et cetera.  And then of course, screening for the hypertension, hyperlipidemia, metabolic syndrome with basically you or myself or somebody kind of like us serving, many times it's the role of the PCP, just making sure we're checking out, you know, CBC, CMP, et cetera, lipid parameters to screen for those kind of cardiac associated issues along with secondary malignancies. Dr. Pedro Barata: So that's super comprehensive and thorough. Thank you so much. Actually, I love how you break it down in a simple way. Two functions of the testes, produce testosterone and then, you know, the problem related to that is the hypogonadism, and then the second, as you mentioned, produce sperm and of course related to the fertility issues with that.  So, let's start with the first one that you mentioned. So, you do cite that in your paper, around 5-10% of men end up getting, developing hypogonadism, maybe clinical when they present with symptoms, maybe subclinical. So, I'm wondering, for our audience, what kind of recommendations we would give for addressing that or kind of thinking of that? How often are you ordering those tests? And then, when you're thinking about testosterone replacement therapy, is that something you do immediately or are there any guidelines into context that? How do you approach that? Dr. Aditya Bagrodia: So, just a bit more on digging into it even in terms of the questions to ask, you know, "Do you have any decrease in sexual drive? Any erectile dysfunction? Are your morning erections still taking place? Has the ejaculate volume changed? Physically, muscle mass, strength? Have you been putting on weight? Have you noticed increase in body fat?" And sometimes this is complicated because there's some anxiety that comes along with a cancer diagnosis when you're 20, 30 years old, multifactorial, hair loss, hot flashes, irritability. Sometimes they'll, you know, literally they'll say, "You know, my significant other or partners noticed that I'm really just a little bit labile." So I think, you know, there's the symptoms and then checking, usually kind of a gonadal panel, FSH, LH, free and total testosterone, sex hormone binding globulin, that's going to be typically pretty comprehensive. So if you've got symptoms plus some laboratory work, and ideally that pre-orchiectomy testosterone gives you some delta. If they started out at an 800, 900, now they're 400, that might be a big change for them. And then, when you talk about TRT (Testosterone Replacement Therapy) recommendations, you know, Pedro, yourself, myself, we're kind of lucky to be at academic centers and we've got men's health colleagues that are ultra experts, but at a high level, I would say that a lot of the TRT options center around fertility goals. Exogenous testosterone treats the low T, but it does suppress gonadal function, including spermatogenesis. So if that's not a priority, they can just get TRT. It should be done under the care of a urologist, a men's health, an endocrinologist, where we're checking liver chemistries and CBCs and a PSA and so forth. If they're interested in fertility preservation, then I would say engaging an endocrinologist, men's health expert is important. There's medications even like hCG, Clomid, which works centrally and stimulate the gonadal access. Niche scenarios where they might want standard TRT now, and then down the way, 5, 7 years, they're thinking about coming off of that for fertility purposes, I think that's really where you want to have an expert involved because there's quite a bit of nuance there in recovery of actual spermatogenesis and so forth.  To kind of summarize, you got to ask about it. Checking it is, is not overly complicated. We do a baseline pre-orchiectomy and at least once annually, you can tag it in with the tumor markers, so it's not an extra blood draw. And if they have symptoms of course, kind of developed, then we'll move that up in the evaluation. Dr. Pedro Barata: Got it. And you also touch base on the fertility angle, which is truly important. And I'm just curious, you know, a lot of times many of us might see one, two patients a year, right, and we forget these protocols and what we've got to do about that.  And so I'm interested to hear your thoughts about when you think about fertility, and how proactive you get. In other words, who do you refer for the fertility clinic, for a fertility preservation program? You know, do all cases despite getting through orchiectomy or just the cases that you're going to, you know you're going to seek chemotherapy at some point? What kind of selection or it depends on the chemo, like how do you do that assessment about the referral for preservation program that you might have available at UCSD? Dr. Aditya Bagrodia: Yeah, I mean I feel really fortunate to sit on the NCCN Testis Cancer Guidelines. It's in there that fertility counseling should be discussed prior to orchiectomy. So 100% bring it up. If there are risk factors, undescended testicles, previous history of fertility concerns, atrophic contralateral testicle, anything on the ultrasound like microlithiasis in the contralateral testicle, you kind of wanna get it there. And then again, there's kind of niche scenarios where you're really worried, maybe get a semen analysis and it doesn't look that good, arrange for the time of orchiectomy to have onco-testicular sperm extraction from the, quote unquote, "normal" testis parenchyma. You know, I think you have to be kind of prepared to go that route and really make sure you're doing this completely comprehensively.  So pre-orchiectomy all patients. Don't really push for it too hard if they've got a contralateral testicle, if they've had no issues having children. There's some cost associated with this, sperm banking still isn't kind of covered even in the context of men with cancer. If they've got risk factors, absolutely pre-orchiectomy. Pre-RPLND, even though the rates of ejaculatory dysfunction at a high-volume center should be low single digits, I'll still offer it. That'd be a real catastrophe if they were in that small proportion of patients and now they're going to be reliant on things like intrauterine insemination, where it becomes quite expensive.  Pre-chemo, everybody. That's basically a standard these days where it should be discussed and it's kind of amazing currently, even if you don't have an accessible men's health fertility clinic, there are actually companies, I have no vested interest, Fellow is one such company where you can actually create an account, receive a FedEx semen analysis and cryopreservation kit, send it back in, and all CLIA certified, it's based out of California. The gentleman that runs it, is a urologist and very, very bright guy who's done a lot of great stuff for testis cancer. So, even for patients that are kind of in extremis at the hospital that kind of need to get going like yesterday, we still discuss it. We've got some mechanisms in place to either have them take a semen analysis over to our Men's Health clinic or send it off to Fellow, which I think is pretty cool and that even extends to some of our younger adolescent patients where going to a clinic and providing a sample might be tricky.  So, I think bringing it up every stage, anytime there's an intervention that might be offered, orchiectomy, chemo, surgery, radiation, it's kind of incumbent on us to discuss it. Dr. Pedro Barata: Gotcha. That's super helpful. And you also touch base on another angle, which is the psychosocial angle around this. You mentioned suicidal rates, you mentioned anxiety, perhaps depression in some cases as well as chronic fatigue, not necessarily just because of the low testosterone that you can get, but also from a psychological perspective. I'm curious, what do the recommendations look like for that? Do these patients need to see a social worker or a psychologist, or do they need to answer a screening test every time they come to see us and then based on that, we kind of escalate, take the next steps according to that? Do they see a psychologist perhaps every so often? How should that be managed and addressed? Dr. Aditya Bagrodia: It's an excellent question and again, these can be rather insidious symptoms where if you don't really dig in and inquire, they can be glossed over. I mean, how easy to say, "Your markers look okay, your scans look okay. See you in six months," and keep it kind of brief. First off, I think bringing it up proactively and normalizing it, that, "This may be something that you experience. Many people do, you're not alone, there's nothing kind of wrong with you." I also think that this is an area where support groups can be incredibly useful. We host the Testicular Cancer Awareness Foundation support group here. They'll talk about chemo brain or just like a little bit of an adjustment disorder after their diagnosis. Support groups, I think are critical. As I mentioned, we have a survivorship program that's led by a combination of our med oncs, myself on the uro-onc side, as well as APPs, where we are systematically asking about essentially the whole litany of issues that may arise, including psychosocial, anxiety, depression, suicidality. And we've got a nice kind of fast path into our cancer center support services for these young men to meet with a psychologist. If that isn't going to be sufficient, they can actually see a psychiatrist to discuss medications and so forth. I do think that we've got to screen for these because, as anticipated from diagnosis, those first 2 years, we see a rise. But even 10, 15 years out, we note, compared to controls, that there is an increased level of anxiety, depression, suicidality that might not just take place at that initial acute period of diagnosis and treatment. Dr. Pedro Barata: Really well said. Super important.  So I guess if I were to put all these together, with these really amazing advances in technology, we all know AI, some of us might be more or less aware of biomarkers coming up, including microRNA for example, and others, like as I think of all these potential long term complications for these patients, look at the future, I guess, can we use this as a way to deescalate treatment where it's not really necessary, as a way to actually prevent some of these complications? Like, how do we see where we're heading? As we manage testicular cancer, let's say, within the next 5 or 10 years, do you think there's something coming up that's going to be different from what we're doing things today? Dr. Aditya Bagrodia: Totally. I mean, I think it's as exciting as a time as there's ever been, you know, maybe notwithstanding circa 1970s when platinum was discovered. So microRNAs, which you mentioned, you know, there's a new candidate biomarker, microRNA-371. We are super excited here at UCSD. We actually have it CLIA-certified available in our lab and are ordering these tests for patients kind of in their acute stage, you know, stage one and surveillance, stage two, post-RPLND, receiving chemotherapy. And essentially this is a universal germ cell tumor specific biomarker, except for teratoma, suffice it to say 90% sensitive and specific. And I think it's going to change the way that we diagnose and manage patients. You know, pre-orchiectomy, that's pretty straightforward. Post-orchiectomy, maybe we can really decrease the number of CT scans that are done. Maybe we can identify those patients that basically have occult disease where we can intervene early, either with RPLND or single cycle chemo. Post-RPLND, identify the patients who are at higher risk of relapse that may benefit from some adjuvant therapy. In the advanced setting, look at marker decline for patients in addition to standard tumor markers. Can we modulate their systemic therapy?  So, the international interest is largely on modifying things. There's really cool clinical trials that we have for stage one patients, that treatment would be prescribed based on a post-orchiectomy microRNA. I think the microRNAs are really exciting. Teratoma remains an outstanding question. I think this is where maybe ctDNA, perhaps some radiomics and advanced imaging processing and incorporating AI may allow us to safely avoid a lot of these post-chemo RPLNDs. And then identification using SNPs and so forth of who might be most susceptible to some of the cardiac toxicity, autotoxicity and personalizing things in that way as well. Dr. Pedro Barata: Super exciting, right, what's about to come? And I agree with you, I think it's going to change dramatically how we manage this disease.  This has been a pleasure sitting down with you. I guess before letting you go, anything else you'd like to add before we wrap it up? Dr. Aditya Bagrodia: Yeah, first off, again, just want to thank you and ASCO for the opportunity. And it's easy enough to, I think, approach a patient with the testicular germ cell tumor as, "This is an easy case. We're just going to do whatever we've done. Go to the guidelines that says do X, Y, or Z." But there's so much more nuance to it than that. Getting it done perfectly, I think, is mandatory. Whatever we do is an impact on them for the next 50, 60, 70 years of their life. And I found the germ cell tumor community, people are really passionate about it. If you're ever uncertain, there's experts throughout the country and internationally. Ask somebody before you do something that you can't undo. I think we owe it to them to get it perfect so that we can really maximize the survivorship and the survival like we've been talking about. Dr. Pedro Barata: Aditya, thanks for sharing your fantastic insights with us on this podcast. Dr. Aditya Bagrodia: All right, Pedro. Fantastic. Appreciate the opportunity. Dr. Pedro Barata: And also, thank you to our listeners for your time today. I actually encourage you to check out Dr. Bagrodia's article in the 2025 ASCO Educational Book. We'll post a link to the paper in the show notes. Remember, it's free access online, and you can actually download it as well as a PDF. You can also find on the website a wealth of other great papers from the ASCO Educational Book on key advances and novel approaches that are shaping modern oncology.  So with that, thank you everyone. Thank you, Aditya, one more time, for joining us. Thank you, have a good day. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:         Dr. Pedro Barata  @PBarataMD   Dr. Aditya Bagrodia @AdityaBagrodia Follow ASCO on social media:         @ASCO on X (formerly Twitter)         ASCO on Bluesky        ASCO on Facebook         ASCO on LinkedIn         Disclosures:      Dr. Pedro Barata:  Stock and Other Ownership Interests: Luminate Medical  Honoraria: UroToday  Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon  Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas  Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck   Dr. Aditya Bagrodia: Consulting or Advisory Role: Veracyte, Ferring  

TITANIC A young aristocratic woman named Rose, suffocating in a rigid engagement, falls for free-spirited third-class passenger Jack Dawson aboard the unsinkable ocean liner - Titanic. Their secret romance defies class and her possessive fiancé as the ship sails toward disaster. When it hits an iceberg, their struggle to survive reveals love, sacrifice, and the brutal divide between those rescued and those left behind. Craig, Elisabeth and guest Ryley Brown talk about touchstone cinema, historical fiction, PCP chowder and the movie “Titanic” on this week's Matinee Heroes. Show Notes 1:20 Craig, Elisabeth and Ryley Brown talk about boats. 7:37 Craig, Elisabeth and Ryley discuss "Titanic" 1:08:03 Recasting 1:44:36 Double Feature 1:47:42 Final Thoughts 1:56:31 A preview of next week's episode "Ben-Hur" Our next no-ender is the biblical fiction "Ben-Hur"

Dave and Cody dive deep into House of Dynamite, Kathryn Bigelow's nail-biting new nuclear thriller that's equal parts technical masterpiece and moral Rorschach test. Is it brilliant minimalism—or a cinematic blue screen of death?They also break down the possible sale of Warner Bros. Discovery, what it could mean for movie theaters, and whether James Gunn's fledgling DCU survives a Netflix takeover.It's the perfect PCP blend of wit, wonder, and way-too-much coffee.Cold Open: Dave overshares at the coffee drive-thru ☕Pop Culture News:Why Warner Bros. might be up for saleThe Netflix wildcard and the ripple effect on theatersThe DCU's uncertain future under Gunn & SafranMain Review: House of DynamiteMultiple perspectives, one moral bombThe power of restraint vs. reactionIdris Elba's presidential gravitasWhat works, what fizzles, and why the ending divides everyoneWinner & Loser of the MovieThe Lobby Q&A

Flu season - 1:44 Flu and when to go to the PCP - 1:57 Parenting tip - 8:05 Trivia segment - 9:05 Conclusion - 9:18

Send us a textHello Fellow Airgun Geeks,The Airgun Geeks Podcast welcomes two of the biggest names in the airgun world—Chris “The Turret” Turek of Up North Airgunner and Officer PJ Clarke of The Wisconsin Airgunner!In this episode, we dive deep into: Chris's first place win at the 2025 Extreme Benchrest (EBR) competition The controversial topic of airgun modifications and how they affect manufacturer warranties The behind-the-scenes mindset of top-tier airgun competitors How far you can push your airgun without crossing the lineWhether you're a PCP shooter, benchrest competitor, or just love precision gear, this conversation is packed with insights, laughs, and pro-level advice.Support the show

Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access.  A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it's the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbursement that pushes clinicians toward concierge and direct primary care, and payer tactics that encourage consolidation rather than capacity.Kaufman and Helppie then get specific about the economics. Medicaid rates that barely cover overhead lead practices to cap panels, while insurers play separate groups against each other until they merge, gaining leverage but not necessarily improving availability. Primary care, which should function like a straightforward retail experience, is instead forced through insurance mechanics that add friction to simple, high-value services. The result is predictable: over 40 percent of ER visits come from Medicaid patients who couldn't access timely outpatient care, and the most vulnerable pay the highest price in avoidable emergencies.Their conversation wrestles with the big numbers and the real trade offs. Ten percent of patients drive more than 80 percent of spending across Medicare and commercial plans. Pharma's incentives to expand lifelong demand clash with insurers' incentives to deny care. The federal government, the largest health benefits organization in the world, changes leadership every few years, making long-term workforce planning and access expansion difficult. They outline pragmatic moves that can help now: secure continuity with direct primary care or concierge if possible, build a relationship with a PCP who can open specialist doors, and for complex care, shop outcomes rather than prices.If you've felt the squeeze—months-long waits, denials, or a scramble for appointments—this conversation gives language, data, and practical options. Listen to understand why access is collapsing, what levers could ease the pressure, and how to protect your path to timely, high-quality care today. If the ideas resonate, follow and share, and leave a review with your own access story—what worked, what didn't, and what needs to change next.Support the showEngage the conversation on Substack at The Common Bridge!

O respeito pelos deputados do PCP: “Aquele senhor sofreu como eu não sofri”. A matança da Páscoa: “O primeiro exercício de guerra híbrida em Portugal”. O 25 de novembro. E ainda Sá Carneiro, Cunhal, Melo Antunes e Ramos Horta, vistos por Ângelo Correia.See omnystudio.com/listener for privacy information.

Pop Culture Pastor dives headfirst into the fog. Dave and Cody rewind Frank Darabont's soul-crusher The Mist (2007): why the human breakdown still hits, why Marcia Gay Harden steals the whole movie, and how that ending becomes a parable about quitting one step too soon. They riff on what holds up and what doesn't, then play the show's greatest hits: Muppet-ize the Movie, Which Character Would You Be? and the Winner & Loser of the movie (sorry, Stephen King… Darabont's ending wins).Plus: a spicy news bit on the “least attractive hobbies for men” list (video games, figurines, crypto, trolling, gambling) and why maybe the problem isn't hobbies—it's imbalance.Come for the monsters, stay for the meaning.Agree? Hate it with a white-hot passion? Sound off and tag the show.Subscribe, rate, and check the PCP swag in the Linktree— https://linktr.ee/PopCulturePastorPod

If you don't invest in your weaknesses now, they will haunt you down the road.This conversation originally aired on Episode 13 of Long Run Labs, my new podcast on the business of the outdoor industry.Alex is the Founder and CEO of Eternal. Before founding Eternal, Alex was the founder and CEO of The Athletic, a subscription sports media company founded in 2016. The Athletic reached 1M paid subscribers faster than any publishing company in history and sold to The New York Times in 2022 for $550M. Prior to The Athletic, Alex ran Product & Design for Strava, helping the platform go from 800 users to 10s of millions. Originally from Philadelphia, Alex lives in Presidio Heights with his wife, two kids, and golden retriever. Jon chats with Alex about:​Alex's Journey as a Runner and Endurance Athlete​Building Strava's Growth and Community​The Athletic's Creation and Success Story​Founding Eternal and Its Mission​Leadership Philosophy and Team BuildingStay connected:Follow Alex:https://x.com/amatherhttps://www.linkedin.com/in/alexemather/This episode is supported by:​Tifosi Optics: Fantastic sunglasses for every type of run. Anti-bounce fit, shatterproof, and scratch resistant. Get 20% off when you use this link!​Janji: Use code “FTLR” at checkout when shopping at janji.com for 10% off your order and see why Janji is the go-to for runners who want performance gear made to explore. All apparel is backed by a 5 year guarantee, so you know it's meant to last!​Eternal: Eternal is a performance health company for runners, endurance athletes, and anyone serious about their training. Eternal just added PCP capabilities for those in NY and CA to answer the question of, “so, does this mean you're my doctor?”​PUMA: Get your pair at your local Fleet Feet or your favorite local running shop!​AmazFit Check out the T-Rex 3 and a selection of GPS watches at amazfit.com and use code “FTLR” for 10% off.